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ABSTRACT 
 
Down’s syndrome (DS) is associated with multiple musculoskeletal (MSK) features, including 
hypermobility and inflammatory arthritis. MSK disorders are not included in the screening 
programme for these children and correct diagnosis of MSK problems can be missed or delayed. 
 
This study aimed to identify and examine the population of children with DS resident in Greater 
Glasgow to determine the frequency of musculoskeletal disorders and the levels of associated 
physical disability, particularly hypermobility, podiatric disorders, arthritis and obesity levels. 
 
Between Jan 2011-2012 147 children with DS, aged between two and sixteen years and resident in 
Greater Glasgow and Clyde Health Board by postcode were identified from the Glasgow Thyroid 
and community paediatricians’ register. They were invited to a single study visit encompassing 
musculoskeletal and podiatric examinations, anthropometric measurements and completion of 
study questionnaires. Focus groups were carried out to establish knowledge of MSK disorders in 
professionals likely to encounter this population. 
 
Seventy three children participated in the study.  A high level of hypermobility was identified, 
characterized by predominance in the weight bearing joints of the lower limbs, especially hips 
(77%), ankles (56%) and feet (59%). Standard measures of hypermobility failed to identify the 
extent and severity of hypermobility in these children, identifying only 15% of children as having 
hypermobility syndrome. No new cases of arthritis were identified in the study cohort. Families 
reported a lack of expression of pain.  Ten percent of the cohort were obese, compared to 20% in 
the UK cohort from which DS growth charts are derived. Focus groups identified concerns from 
professionals about knowledge and skills in identifying musculoskeletal problems in these children, 
and challenges in ascribing an appropriate diagnosis. 
 
This study identified barriers to care for a range of MSK pathologies in DS which targeted 
education and disease specific structuring of services could address.  Rheumatologists found that 
expectations for MSK functioning in this population were low. Education focusing on the 
recognition and accurate assessment of altered or deteriorating MSK function is required. Severe 
and extensive hypermobility combined with altered expression of pain were found in this 
population, adding diagnostic challenges. Current MSK examination tools for hypermobility and 
hypotonia did not perform well in this population.  Current health screening structures, the 
education and expectations of those providing health screening were identified as further barriers to 
MSK diagnosis.  Facilitating early and accurate MSK diagnosis through the development of MSK 
examination tools, targeted education and structuring services for this population are important for 
the MSK and broader health of these children.    
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CHAPTER 1 
 
INTRODUCTION 
 
Children with Down’s Syndrome (DS) are well described as having a wide range of 
musculoskeletal (MSK) problems ranging from atlanto-axial subluxation to inflammatory arthritis.  
This study aimed to determine the prevalence and characteristics of MSK problems in a population 
of children with DS resident in Greater Glasgow.  
 
Research Objective 
 
To determine the frequency of musculoskeletal disorders in children with Down’s syndrome and 
the levels of associated physical disability. 
 
Secondary research objectives 
 
1. To determine the proportion of children with Down’s syndrome who are hypermobile and 
the associated levels of impairment and disability. 
2. To determine the proportion of significant foot abnormalities and associated levels of 
disability.  
3. To determine the proportion with arthritis and the associated levels of disability  
4. To determine the proportion who are significantly overweight contributing to their 
musculoskeletal disability. 
5. To determine barriers to prompt diagnosis and treatment. 
6. To carry out focus groups to determine current level of knowledge of and concerns 
regarding MSK disorders in this population 
 
Literature has described children with Down’s syndrome as having with a chronic inflammatory 
arthritis that is similar to juvenile idiopathic arthritis (JIA) and suggested this may be more 
prevalent in children with Down’s syndrome than the prevalence of JIA in the general population 
(Yancey et al (1984), Olson et al (1990), Padmakumar et al (2002), Juj et al (2009)). Within the 
rheumatology department at RHSC, Glasgow, a pilot study assessing the numbers of children who 
attended with Down’s arthritis, compared to the number of children attending with JIA, suggested 
that inflammatory arthritis was more common in the Down’s population. The children with Down’s 
syndrome who attended our service also displayed evidence of prolonged, undiagnosed and severe 
18 
 
 
 
disease.  This was despite multiple documented consultations with different health professionals 
who documented the features, but who failed to diagnose inflammatory arthritis (Cruickshanks et 
al, 2008). 
 
This study aimed to screen children (before their 16th birthday) with Down’s syndrome who were 
resident in Glasgow during the study period for a wide range of MSK problems . A single study 
visit involved a full examination of the musculoskeletal system, documenting any signs and 
symptoms of musculoskeletal disorders such as atlantoaxial instability, hypermobility, hip 
instability and patellofemoral instability, inflammatory arthritis, a detailed foot exam and gait 
assessment, anthropomorphic characteristics, a parent interview and questionnaires.  
 
It is known from literature that these children are more prone to hypotonia, hypermobility and 
common podiatric disorders and from the above examinations we aimed to determine the level and 
prevalence of musculoskeletal disability caused by these problems and assess for possible arthritis. 
Height and weight were recorded to assess obesity levels within the study population and 
questionnaires used to ascertain any parental concerns.  
 
It also aimed to identify any training needs for health professionals within the community setting to 
improve the early diagnosis of MSK problems. The RHSC pilot study (Cruickshanks et al, 2008) 
raised concerns over delay to diagnosis as the children with DS were presenting with severe 
disease. It was decided to carry out focus groups with a group of community paediatricians to 
determine level of knowledge of MSK disorders in this population and with paediatric 
rheumatology specialists to determine concerns regarding referral and diagnosis. Discussion with 
the community paediatricians included current practice within the annual health review these 
children receive, and whether they included a musculoskeletal examination. Discussion with the 
paediatric rheumatology specialists included experience of DS children presenting with arthritis 
and response to treatment to assess delay to diagnosis and prognosis at presentation. We intend to 
develop an educational package to raise awareness of MSK problems in this population for the 
healthcare professionals who see these children regularly and to allow them to feel confident 
examining for musculoskeletal disorders, and highlight the MSK features of DS to the children’s 
parents to facilitate early presentation. 
 
I have worked in various settings during my nursing career but started working in research three 
years ago within the rheumatology team at the Royal Hospital for Sick Children (RHSC), Glasgow 
and have very much enjoyed evolving my role as a nurse in this new direction. I have found it very 
rewarding working with children and their families on studies and learning the processes involved 
in a number of research projects. In particular I have found the children with Down’s syndrome a 
delight to work with. 
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This thesis commences with a literature review followed by a chapter on methodology. The fourth 
chapter is about the themes obtained from focus groups discussions. Chapters five, six, seven cover 
results in hypermobility, musculoskeletal and podiatry and Chapter eight concludes with my 
discussion chapter. 
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CHAPTER 2 
 
LITERATURE REVIEW  
 
2.1 Literature search strategy 
 
A literature search was carried out using PubMed UK, Glasgow University Library (Cinahl, 
Medline and Biomedical Reference Collection), Greater Glasgow & Clyde Health Board 
Knowledge network, Wiley Online Library and Google Scholar. The phrases ‘arthritis in Down* 
syndrome’; ‘arthritis’; ‘Down* syndrome’; ‘children with Down* syndrome’; ‘Down* syndrome 
and general practice’; ‘joints’; ‘psoriatic arthritis’; ‘psoriatic arthritis in children’; ‘arthropathy’; 
‘inflammatory arthropathies’; ‘podiatric’; ‘podiatry’; ‘leg length discrepancy in children’, 
‘metatarsal formula’, ‘pain and Down* syndrome’; ‘general care in Down* syndrome’; ‘head 
circumference and Down* syndrome’; ‘communication in Down* syndrome’; ‘Special Olympics’; 
‘Special Olympics exclusion’; ‘Down* syndrome athletes’ ‘musculoskeletal’; ‘musculoskeletal 
exam’; ‘CHAQ’; ‘pGALS’ ‘hypermobility’, ‘medical ethics’, ‘principles of medical ethics’ and 
‘unethical research’ were entered into the databases. No specific year restrictions were added to the 
search as quite a number of the relevant articles date back over 30 years but, mainly, literature from 
2000 and 2011 was used for current relevance. Only English articles were included in the search. 
Numerous results were returned for each phrase of which many were not relevant. Papers were 
generally eliminated based on the title but a small number were eliminated due to abstract if the 
title appeared relevant. A large number of relevant results were returned, particularly on atlanto-
axial instability, and other musculoskeletal disorders. A number of the articles found were reviews 
of the literature of their particular subject. The Google search engine was also used to search for 
‘John Langdon Down’, the man who originally described Down’s syndrome, which provided 
various versions of his life story and a link to his original paper classifying Down’s syndrome.  
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2.2 Historical Perspective 
Classification of Down’s syndrome and John Langdon Down 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture 2.1 - John Langdon Down (www.langdondowncentre.org.uk) 
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Down’s syndrome (DS) was originally described by John Langdon Down (Picture 2.1) in his 1866 
paper ‘Observations on an Ethnic Classification of Idiots’. His observation was that some patients 
had features that could be likened to different ethnicities such as Ethiopian and Malayan. In 
particular he was intrigued by a large group of patients who displayed the same physical features. 
Down likened these features to the people of Mongolia. He described the similarity in their facial 
features in depth and remarked that this was so marked that these children could be siblings. He 
noted that these were features present in more than 10% of his cases and it is always a congenital 
condition. He concentrated his time measuring head circumferences, studying photographs and 
examining the brains of these children post mortem.  
 
Following publication of his paper these patients were then described as Mongols or Mongolian 
Idiots until the 1960s. They were then reclassified as Down’s syndrome. The Editor of the Lancet 
opted for the description Down’s syndrome after a group of 20 leading geneticists wrote suggesting 
differing options. The World Health Organisation confirmed this change in 1965. (Ward, 2002). 
This decision was taken after a request from the People’s Republic of Mongolia. However, despite 
this reclassification, the term mongol was still used into the 1980s. (Kinnell, 1984) 
 
In 1866 mentally ill patients were termed as idiots, imbeciles and lunatics and placed in 
institutions. Although Down’s paper would be considered inappropriate in current times, it was 
written at a time when these terms were used widely and John Langdon Down was not describing 
his patients in a derogatory fashion. His description of racial similarity was a recognition of 
consistently found clinical features which has led to an understanding of distinct clinical syndromes 
and the discovery of the genetic process involved. This has provided further understanding of the 
mechanisms of DS and contributes to understanding of congenital disorders generally.  
 
Down became concerned that all people with any sign of mental illness or disability were branded 
as idiots with no distinction between levels of learning disability. He discovered that people with 
DS improved better than he would have expected with direct involvement and teaching.. He 
preferred the term ‘feeble minded’ rather than idiots and, after being Medical Superintendant of 
Earlswood Asylum for Idiots for 10 years, he opened up his own home, Normansfield, as a 
residential training and care centre for the learning disabled (www.langdondowncentre.org.uk).   
 
Normansfield started as a family home with 20 patients but over 23 years, was expanded and grew 
to a home housing 150 patients. The patients were encouraged to learn, play and interact. The home 
incorporated a theatre (Picture 2.2) where they had Sunday services and put on shows and concerts. 
It appears that John Langdon Down was a very liberal, open minded person at a time when 
opinions were considerable narrower than today. He was also known for supporting the suffragette 
movement. Normansfield remained as a home for people with learning disabilities and run by the 
23 
 
 
 
Langdon Down family for 100 years (the advert in Picture 2.3 shows his sons as the medical 
superintendents). It is now occupied by the Down’s Syndrome Association and the theatre is used 
for professional productions.   By a strange twist of fate, one of John Langdon Down’s 
grandchildren was born with DS (after his death) and lived at Normansfield until he died aged 65. 
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                Picture 2.2 Normansfield Theatre (www.langdondowncentre.co.uk) 
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Picture 2.3 Advert for Normansfield  
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2.3 Down’s syndrome 
 
Following John Langdon Down’s description, many different studies examined the epidemiology 
of  DS. One of the earliest conclusions to an increased risk of a pregnancy with DS was that 
increased maternal age was a factor (Penrose, 1933; Howells, 1989; Bosch, 2003; Roizen and 
Patterson, 2003; Bittles and Glasson, 2004; Kava et al, 2004; Sherman et al, 2007; Weijerman et al, 
2010). Penrose (1933) examined maternal and paternal age in relation to DS births and discovered 
that increased maternal age was much more significant than increased paternal age.  
 
In 1959 the presence of an extra chromosome 21 was discovered in DS due to the introduction of 
karotyping (Roizen and Patterson, 2003; Sherman et al, 2007) and has subsequently also become 
known as trisomy 21.  
 
Prenatal testing for DS was introduced in the 1970s (Roizen, 2001) and was originally an invasive 
amniocentesis in the second trimester but has progressed to a less invasive combined test of  nuchal 
transparency screening using ultrasound and a blood test for beta-human chorionic gonadotrophin 
and pregnancy-associated plasma protein-A (Nice Guidelines CG62, 2008) . Introduction of 
screening has appeared to affect the number of children born with DS as it has allowed women to 
have the choice to terminate or continue with the pregnancy. However not all countries have 
widespread access to screening. Kava et al (2004) comment that screening is only offered to 
women over 35 or those with a previous DS pregnancy in India. It is noticeable that the abortion 
law in Eire means the incidence of DS is 10 fold higher than in Glasgow despite a similar sized 
population. (O Killeen and C Foley personal communication) 
 
DS is now considered to be one of the most common chromosomal abnormalities (Howells, 1989; 
Sherman et al, 2007: Weijerman and de Winter, 2010). Prevalence reports of DS have changed 
over the years with Howells (1984) breaking the reporting down into maternal age difference of 1 
in 2500 for mothers under 30, 1 in 1200 for mothers between 29 – 34, 1 in 200 for mothers aged 
between 35 and 39 and 1 in 35 for mothers aged between 39 – 47.  More recent studies in the 
United States suggest  approximately 1 in 700 births are children with DS (Kava et al, 2004; 
Sherman et al, 2010; Prows et al, 2013). Weijerman and de Winter (2010) commented on a world 
wide prevalence of 10 per 10,000 live births but also discussed differences in prevalence around the 
world. One of the reasons for this may be due to attitude and laws surrounding termination of 
pregnancy. Countries where abortion is illegal such as Ireland and United Arab Emirates have 
higher prevalence rates and some countries such as France show lower prevalence rates.  
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2.3.1  Signs and symptoms 
 
The most striking characteristic of DS in a newborn is hypotonia (Weijerman and de Winter, 2010). 
Others include the presence of a transverse line across the palm of the hand called the ‘Simian 
fold’, upward slant to the eyes (epicanthic folds), depressed nasal bridge creating flat facial features 
and a short neck (Bosch, 2003; Roizen and Patterson, 2003; Kava et al, 2004; Sherman et al, 2007; 
Weijerman and de Winter; Prows et al, 2013) 
 
Symptoms include the presence of a coronary heart defect, problems feeding, congenital defect of 
the GI tract including Hirschprung’s disease and hearing loss (Bosch, 2003; Roizen and Patterson, 
2003; Sherman et al, 2007; Weijerman and de Winter, 2010). 
 
Diagnosis should be made through chromosomal karotyping on suspicion of DS. 
 
2.3.2 Health problems in DS 
 
Children with DS are reported as having many health issues. It is well reported that they are at 
increased risk of cardiac disorders, leukaemia, hearing problems, sight problems, thyroid disorders, 
respiratory problems and orthopaedic issues such as hip dysplasia and antlantoaxial instability. A 
few of the most common are discussed below. 
 
2.3.2.1  Coronary defects 
Approximately half of children with DS are reported as having congenital cardiac defects at birth 
with atrioventricular septal defects and ventricular septal defects being the most commonly 
reported (Howells, 1989; Pueschel et al, 1995; Roizen, 1996; Roizen, 2001; Bosch, 2003; Roizen 
and Patterson, 2003; Kava et al, 2004; Sherman et al, 2007; Prows et al, 2013; Weijerman and de 
Winter, 2010). This statistic of approximately 50% appears to be unchanged from Howells paper in 
1989 to Prows et al in 2013. 
 
2.3.2.2  Thyroid disorders 
 
Congenital hypothyroidism has been widely reported in DS (Howells, 1989; Pueschel et al, 1995; 
Roizen, 1996; Roizen, 2001; Bosch, 2003; Roizen and Patterson, 2003; Weijerman and de Winter, 
2010) and children are screened at birth, then generally screened annually for thyroid problems.  
One of the sources for our population was the Glasgow Thyroid Register.  
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2.3.2.3  Sensory problems 
 
Auditory and visual problems are observed in children with DS such as congenital cataracts, 
nystagmus, blepharitis, glaucoma, middle ear effusions and distortion of the tympanic membrane 
(Howells, 1989; Pueschel et al, 1995; Roizen, 1996; Roizen, 2001; Roizen and Patterson, 2003; 
Kava et al, 2004; Weijerman and de Winter, 2010; Prows et al, 2013). 
 
2.3.2.4  Gastrointestinal problems 
 
Gastrointestinal problems are documented in DS and can be found in approximately 10% of the 
population (Pueschel et al, 1995; Bosch, 2003; Sherman et al, 2007; Weijerman and de Winter, 
2010). These conditions include Hirschprung’s disease, perforations and duodenal stenosis.  
 
2.3.2.5  Leukaemia 
 
Children with DS are known to have a higher risk of developing acute myeloid and lymphoblastic 
leaukaemia and may also present with other haematological disorders such as thrombocytopenia 
and polycythaemia (Bosch, 2003; Weijerman and de Winter, 2010). 
 
2.3.3  Prognosis and Life Expectancy 
 
Life expectancy has increased greatly over the years for individuals with DS as screening and 
newer treatments improve their recovery from associated medical disorders, especially in the first 
year of life as early diagnosis and intervention in coronary defects and gastrointestinal disorders 
have improved mortality rates (Weijerman and de Winter, 2010). Yang et al (2002) examined data 
from death certificates between 1983 and 1997 and discovered that the median age of life 
expectancy rose from 25 years in 1983 to 49 years in 1997. Life expectancy in the early part of the 
20th century was approximately 9 years but more recent figures have suggested that median life 
expectancy is now approximately 60 years of age (Bittles and Glasson, 2004; Bittles et al, 2006). 
 
29 
 
 
 
2.4 Recognised associated health problems in Down’s syndrome 
 
John Langdon Down studied facial features, head circumference and brain size in these children. 
He took numerous photographs of these children (Picture 2.4, Picture 2.5) to assist his research. 
The only physical condition he mentions is that ‘the circulation is feeble’ (Down, 1866). Other 
physical conditions are not considered in his paper. Despite this, it is very interesting to note that 
the girl in John Langdon Down’s photograph on the frontispiece shows marked arthritis in her 
hands (Picture 2.6). However, his interest in their wellbeing was a huge leap forward for people 
with DS. 
 
Many different medical conditions have been described in children with Down’s syndrome as in 
section 2.3.2. In the articles discussing the various associated medical conditions, the authors 
mention atlantoaxial instability, hip instability, patellofemoral instability, hypermobility and 
hypotonia under musculoskeletal disorders but for the purposes of this study it is important to note 
that they fail to mention inflammatory arthritis except for Roizen and Patterson who mention it 
briefly and suggest vigilance is required. This will be explored fully later in this chapter.  
 
Cardiac, respiratory and thyroid problems are well documented in DS as are higher risks of 
leukaemia and Alzheimer’s disease. Certain orthopaedic disorders are also well documented such 
as atlanto-axial instability, hip dysplasia, patellofemoral instability and hypermobility. 
Inflammatory arthritis is not so well researched other than a small number of studies looking at 
case reports of children already diagnosed with inflammatory arthritis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                         
 
 
 
 
 
Picture 2.4 - pictures of girls with DS taken by John       Picture 2.5 – pictures of girls with DS  
Langdon Down in the 1800s         taken by John Langdon Down in the 1800s  
(www.intellectualdisability.info)        (www.intellectualdisability.info) 
(picture quality poor as old photos) 
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2.5 Musculoskeletal disorders in DS 
 
2.5.1 Arthritis in Down’s syndrome 
 
Literature on the prevalence of inflammatory arthritis in children with DS is notably limited despite 
evidence of arthritis in the hands of the girl in John Langdon Down’s photograph on the 
frontispiece. (Picture 2.6).  
 
In a letter to the British Journal of Radiology in 1984, H G Kinnell commented that neither he, nor 
his colleagues, had seen cases of rheumatoid arthritis in children with DS. His letter speculated that 
rheumatoid arthritis might be less common in these children than in the general population.  
 
However, in the same year, Yancey, Zmijewski, Athreya and Doughty (1984) published a paper on 
their observations of a number of children with DS who had attended the rheumatology 
department. JIA was termed JRA ( juvenile rheumatoid arthritis) at this time. Seven children were 
described with arthropathy. ‘In 1 patient, hypermobility of the joints could account for the 
arthropathy. In the other 6 children, the arthropathy of Down’s syndrome resembled JRA’ (Yancey 
et al, 1984). They estimated that the prevalence of arthrtitis was much higher in the Down’s 
population. Four of the children had symptoms for some time prior to attending and three didn’t 
appear to respond to treatment. They concluded that this could not be called JRA due to the higher 
prevalence of immune disorders in this population. As JRA was diagnosed following exclusions of 
other diagnoses they classified it as arthropathy of Down syndrome. Subsequent papers, therefore, 
referred to the condition as the arthropathy of Down’s syndrome following this classification. 
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                     Picture 2.6 – girl’s hand showing arthritic change from photo taken 
                     by John Langdon Down in the 1800s  (picture quality poor as old photo) 
 (www.intellectualdisability.info) 
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In a similar study in 1990 Olson, Bender, Levinson, Oestreich and Lovell described nine children 
with the arthropathy of DS. All but one had delay from symptom onset to appointment and Olson 
et al calculated a mean time of 3.3 years in comparison with 0.7 years in the general population. 
Behavioural problems were mistakenly given as the main reason for changes in activities of living 
causing delayed diagnosis of arthritis and they recognised that earlier diagnosis would improve 
with increased awareness of arthritis in this population group. Eight of the nine children either did 
not respond to treatment or had complications resulting from the treatment which led them to query 
whether these patients are more prone to drug toxicities. All the children were treated prior to 
methotrexate therapy being available. All were commenced on non steroidal anti-inflammatories 
with three also on gold therapy and one commenced on hydroxychloroquine.  
 
By 2002 a letter to Rheumatology by Padmakumar, Evans-Jones and Sills (2002) asked ‘Is arthritis 
more common in children with Down’s syndrome?’ They wished to estimate how common arthritis 
was in their population of children with DS. They concluded that the numbers of arthritis in 
children with DS could be three times higher than the general population. However, they only 
identified a small case series of four children and made very generalised estimates of the 
population of DS recognising that their figure could be an underestimate, possibly due to 
misdiagnosis, and a larger study would be required to confirm their findings. They suggested that 
inexperienced examiners might miss arthropathy in these children due to hypermobility and 
unusual hand shape. This would support the suggestion that these children have a delayed time to 
diagnosis for arthritis.  
 
The poster presentation of the pilot study carried out by Cruikshank, Tunc, Walsh, Galea, Davidson 
and Gardner-Medwin (2008) described eight children with DS and arthritis, a similar number of 
cases described by Yancey et al, (1984) and Olson et al, (1990). This looked mainly at the delay to 
diagnosis of inflammatory arthritis. ‘Diagnosis of arthritis in children with Down’s syndrome is 
still significantly delayed compared to other children presenting with inflammatory arthritis’ 
(Cruikshank et al, 2008). The children had attended other health professionals during the course of 
routine screening and review of this population, or for other health reasons, and been given a 
number of misdiagnoses before attending rheumatology despite often documenting of MSK 
symptomatology and in some cases accurate descriptions of synovitis.   This would support the 
idea that developing an education package for other health professionals involved in the care of 
these children might facilitate earlier diagnosis. It would also be beneficial to educate the parents 
who had often identified the MSK concerns to help prevent delay in accessing appropriate services. 
‘Many of this cohort had significant joint damage and disability by time of diagnosis’ (Cruikshank 
et al, 2008). In contrast to previous studies, where treatments were less sophisticated, all but one of 
the children responded well to modern treatment with DMARDS and biologics. Earlier diagnosis of 
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inflammatory arthritis would be likely to significantly improve outcome as it would optimise 
treatment response.  
 
Investigation into delayed diagnosis and response to treatment was continued by Juj and Emery 
(2009) who identified nine children at their hospital who had DS and fulfilled the criteria for JIA. 
They also identified a delay to correct referral and significant joint damage and remarked that lack 
of awareness of inflammatory arthritis in this population led to diagnosis delay and unnecessary 
procedures. Diagnosis delay meant the children presented late and led to irreversible damage to 
joints and functional damage. This study is very recent and, in comparison to the previous studies, 
all of their cases were started on disease modifying therapy, responding well to treatment, with four 
children maintained on methotrexate, one on methotrexate and infliximab, one on 
hydroxychloroquine and one on infliximab. One other child is maintained with anti-inflammatories 
and the ninth child is off all medication. This evidence concurs with Cruickshank et al’s (2008) 
findings that arthritis in DS responds well to modern treatments including biologics. Juj et al 
(2009) linked their findings with Padmakumar’s but suggested that their numbers estimate that 
arthritis is six times more common in DS than in the general population.  
 
All these studies have small and very similar numbers but the fact that they have discovered 
comparable results suggests a trend and gives them more significance than a single study. All 
examined children already diagnosed with JIA and none of them screened populations of children 
with DS which may give a more accurate representation of the prevalence of arthritis. . All support 
the introduction of a musculoskeletal screening tool that would be beneficial to this population. 
‘This and previous studies suggest that the incorporation of arthritis into routine health surveillance 
practices may benefit children with Down’s syndrome’ (Juj and Emery, 2009). Despite these 
conclusions, an MSK examination is still not included in the routine annual review of these 
children.  
 
2.5.1.1 Psoriatic arthritis 
 
Perlman (1984) and Sharma and Dogra (2010) commented that the association between arthritis 
and psoriasis was first reported in the early 1900s but this classification of arthritis may have been 
present as early as the fifth century. Zias and Mitchell (1996) discussed the 1983 excavation of a 
Judean monastery which had been destroyed in 614 AD. Human remains discovered in a tomb 
were examined and, following exclusion of other conditions, two of the remains were diagnosed 
with psoriatic arthritis (PsA). They discussed that it has been agreed that psoriasis was one of the 
more common dermatological conditions regarded as biblical leprosy and by this period of history 
people with these dermatological conditions were housed in monasteries and cared for. Previously 
they had been shunned and expelled. 
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Cruickshank et al (2008) found that the majority of the children reviewed displayed characteristics 
of psoriatic arthritis which is not evident in other literature and queried whether this may be a 
feature in arthritis in DS children. 
 
2.5.2 Atlanto-axial instability 
From the literature reviewed for this study the most frequently recognised and serious MSK 
problem in children with Down’s syndrome is atlanto-axial instability (AAI). This is excessive 
mobility in the first and second cervical vertebrae (the atlantoaxial joint) and is caused by the laxity 
of the transverse atlantal ligament. People with DS can be prone to cervical spine instability due to 
lax ligaments and literature seems to suggest it could be present in approximately 10-20% of them. 
(Collacott, 1987; Roy, 1990; King, 2005; Ali et al, 2006). Of these 10-20% approximately 1-2% 
will develop symptoms (Ali et al, 2006). However AAI is generally asymptomatic and mainly 
diagnosed by radiography. The main concern with AAI in children with DS is spinal cord 
compression causing paralysis although placing restriction on activities in this population to 
prevent complications of AAI can then impact on their obesity levels which places pressure on the 
MSK system in general.  
 
Ali, Al-Bustan, Al-Busairi, Al-Mulla and Esbaita (2006) looked at 44 Kuwaiti subjects with 
Down’s syndrome who were identified because they received primary health care through the two 
state run institutes. The subjects were all adult over the age of 15. A study history was taken, 
physical examination carried out and radiological views of the cervical spine taken in neutral and 
flexion positions looking at anterior atlanto-odontoid distance (AAOD) and posterior atlanto-
odontoid distance (PAOD). Two researchers separately carried out the physical exam and read the 
X-rays, each blind to the others results. 
 
Their results showed eight out of the 44 subjects showed AAI on radiology (18%) and all were 
asymptomatic. This is consistent with the above references suggesting 10-20% of individuals may 
be affected and that AAI is generally asymptomatic (Roy, 1990; King, 2005).  
 
The study by Ali et al had a small number of participants but the authors acknowledged by 
discussing that lacking controls is a possible drawback as a control group would give more 
evidence for any radiological findings in the DS group. Their thorough review of all the evidence 
and previous literature made a good case for imaging the PAOD as well as AAOD as it indicates 
the space available for the cord. They discussed that patients diagnosed with AAI on X-ray may not 
have symptoms if the PAOD is ample as cord compression may not occur. 
This study looked at the diagnosis of AAI quite thoroughly but would have benefit of a higher 
number of subjects and a control group to compare the radiographic results. They made very valid 
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points about positioning of cervical spine for X-ray and areas of the spine to image which confirms 
previous study outcomes as this has been very widely researched. 
 
As AAI is generally asymptomatic it does not have a great impact on the health of the majority of 
children with DS. However these children can be restricted in the types of activities they can 
participate in due to the risk of AAI. Sports considered high risk can include diving, martial arts, 
high jump, football, rugby and gymnastics but other situations such as road traffic accidents are 
also considered high risk for AAI. 
 
 The Special Olympics Committee instigated a screening policy for atlantoaxial subluxation in all 
athletes with DS (Tassone and Duey-Holtz, 2008). Athletes with DS must have a radiological exam 
prior to taking part in sporting activities considered high risk. If X-rays show any sign of 
instability, the athlete is restricted from participating in any of these activities. Similarly to Ali et al 
(2006), Tassone and Duey-Holtz discussed the importance of taking X-rays in flexion and 
extension and also the importance of consideration of cord space as it increases the significance of 
using X-ray to predict the level of risk.  
 
Cremers, Bol, de Roos and van Gijn  (1993) studied AAI and sports risk in children with DS. A 
total of 282 children were examined radiographically and 91 were identified as having an increased 
atlantoaxial distance. These 91 children were divided into two groups to assess the effect of 
sporting activities on the atlantoaxial joint. Group A consisted of 44 children (33 boys) whose 
sporting activities were restricted and Group B consisted of 47 children (32 boys) who were 
allowed to continue normal sporting activities. A third control group of 44 children (25 boys) with 
no evidence of AAI were also included. The study concluded that there was no change to the 
atlantoaxial distance of individual subjects (p=0.99) and that restricting activities actually impacted 
on functional performance.  
 
Although this appeared to be a thorough study and all aspects are described in detail, the tables in 
this study do not show clear numerical results for atlantoaxial distance between groups A and B 
after a year although they state there was no difference and the p value of 0.99 is given in the text. 
They do provide a table for groups B and C and the results show that the difference in atlantoaxial 
distance between these groups was no longer significant after a year ( p=0.19).  
 
Collacott (1987) and Roy et al (1990) both agreed that guidelines and recommendations should be 
in place regarding AAI in Down syndrome. However, this remains a complicated issue with 
lifestyle and neurological signs and symptoms to consider instead of the single assumption that an 
AAOD greater than 3mm leads to dislocation as it suggests that approximately one sixth of the DS 
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population would have their activity levels restricted when the benefits would be greater than the 
risk.   
 
2.5.3 Hypermobility 
 
‘The late Dr Barbara Ansell frequently stated that ‘hypermobility is tricky in children’’ (Bird, 
2005). Joint hypermobility (JH) describes lax ligaments around the joint allowing the joint a wider 
range of movement (ROM) than is considered normal in an asymptomatic individual. Joint 
hypermobility syndrome (JHS) describes this condition but with symptoms which can include joint 
pain, foot pain and joint dislocation. Kirk, Ansell and Bywaters (1967) used the name 
“Hypermobility Syndrome” to describe the situation where joint laxity is linked to musculoskeletal 
symptoms. From review of the literature this is described as the first time the term is used. 
Hypermobility is measured using the Beighton scale (Table 3.3) and hypermobility syndrome 
diagnosed by the Brighton criteria (Table 3.4) 
 
The majority of the literature reviewed described hypermobility and lax ligaments present in DS 
which can precipitate instability problems such as hip and patellar instability and foot deformities. 
(Caird et al, 2006). Despite this, literature that looked at generalised hypermobility in children with 
DS was very limited. The majority of literature looked at hypermobility in relation to joint 
instability, particularly instability of the atlantoaxial joint.  
 
Livingstone and Hirst (1986) examined 39 children (16 girls) with DS identified from a register in 
their local health district and examined their joints for hypermobility. They followed a criteria 
developed by Carter and Wilkinson in 1964 which described a diagnosis based on ‘(1) 
Hyperextension of the elbows beyond 10°. (2) Ability to touch the forearm with the thumb on wrist 
flexion. (3) Hyperextension of the wrist and metacarpal joints so that the fingers lie parallel to the 
forearm. (4) Dorsiflexion of the ankles to 45° or more, from plantigrade. (5) Hyperextension of the 
knees beyond 10°. Abnormal generalized joint laxity was diagnosed if three of these features were 
found bilaterally with both upper and lower limbs being involved’ (Livingstone and Hirst, 1986). 
Livingstone and Hirst found signs of joint laxity in 23 children but showed that only three children 
showed pairs of joints with upper and lower involvement. They, therefore, concluded that the 
orthopaedic problems found in DS were related to hypotonia rather than hypermobility.  
 
The results of this study showed that the strict criteria given by Carter and Wilkinson were 
inappropriate for diagnosing hypermobility and may have been one of the reasons that they were 
revised and the Beighton criteria produced in 1973. These are now accepted internationally and are 
used widely for diagnosis of general joint hypermobility. (Juul-Kristensen et al, 2007).  
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2.6 Hypotonia 
 
Hypotonia is mentioned in much of the literature examining DS, particularly in newborns and. 
Infants with DS are described as floppy at birth (Picture 2.7) and it is one of the most common 
reasons for considering a genetic disorder (Patterson and Lott, 2011; Prows et al, 2013).  
 
Shumway-Cook and Woollacott (1985) studied the dynamics of postural control in the child with 
Down syndrome and discussed that ‘few studies have explored the specific motor control deficits 
that could underlie postural instability and subsequent developmental delay in motor coordination’. 
They compared temporal delay between distal and proximal muscles in a small cohort of 11 
children from the general population and 6 children with DS. They then compared the results from 
the children with results from adults in a previous study. All the children showed a significant 
difference from the adults but although the children with DS showed a delay compared to the non 
DS children it was not a significant difference. They did find that the organisation of postural 
patterns between the control cohort and the DS cohort was considerably different in children under 
three years of age. This is a very small cohort on which to base any conclusions and they do 
suggest that more research is needed to examine whether these results show a difference in 
development in control of posture and not delayed development. This study opens up the question 
that hypotonia may not be the only factor in motor development in DS children and further studies 
would be advantageous in examining this theory.  
 
Latash, Wood and Ulrich (2008) discussed the fact that the majority of literature on motor studies 
in DS mention that hypotonia is a large factor in differences between movement in people with and 
without DS. Their paper examines what is currently known about hypotonia, motor skill 
development and physical activity in DS and interestingly starts with a discussion on muscle tone 
being a frequently used clinical term that has no clear definition and introduce a definition of 
hypotonia for their dicussion which is ‘an examiner moves a joint of a person smoothly and slowly, 
while the person is instructed to relax and not to resist the motion. The examiner compares the 
feeling of resistance to his or her internal gauge based on previous experience what he or she 
associates with being normal and lower than expected resistance is called hypotonia’ (Latash, 
Wood and Ulrich, 2008). This definition is not ideal as it relies on the examiner’s perception of 
what is normal and they suggested that more objective assessment and further research is needed to 
study the relationship between hypotonia and muscle development in children with DS. This paper 
gives the reader some very interesting perspectives and thought provoking questions about 
hypotonia and motor problems in children with DS. 
 
Chang, Kubo and Ulrich (2009) examined muscle activation patterns of eight non DS children 
compared with eight DS children from walking onset for six months. They discovered that both 
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sets of children improved their muscle activation patterns after six months but the DS group did not 
display the same level of stability as their peers and the timing of their muscle bursts was more 
inconsistent. They summarised that both groups demonstrated the need for a prolonged period of 
practice to develop rhythmic and stable muscle activation during gait. Again this is a very small 
cohort and a larger cohort may produce more specific results in differences between the two 
groups.  
 
The majority of the literature mentions hypotonia as a feature of DS without exploring it further. 
Weijerman and de Winter (2010) discussed the care of children with DS and observed that the level 
of hypotonia is directly related to motor developmental delay. Rigoldi et al (2011) examining gait 
development during lifespan in DS mention lax ligaments and hypotonia are typical DS features.  
 
Hypotonia is a well reported and recognised diagnostic sign in DS at birth and some of these 
studies show that postural control in DS children displays deficiencies but hypotonia may not be 
the sole cause of this and further studies are required to explore the issues surrounding motor 
development and hypotonia.  
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 Picture 2.7: Hypotonia in a newborn displaying head lag on pull to sitting and  
  inability to support posture in ventral suspension (Lott, 2012) 
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2.7 Other orthopaedic and musculoskeletal disorders 
 
There are various additional orthopaedic and musculoskeletal disorders recognised in DS, primarily 
hip instability, slipped upper femoral epiphysis, knee problems, particularly patella-femoral 
instability, and scoliosis. Most of these conditions are linked to hypermobility and lax ligaments. 
Jacobsen and Hansson (2000) reviewed orthopaedic disorders in DS. This paper looked at DS in 
general and then sections on the recognised orthopaedic disorders. Each disorder is discussed in a 
fairly brief paragraph but it is noted that arthritis in DS is not mentioned. Interestingly, though, they 
summarised that the DS patient’s lack of communication and lack of awareness of the frequency of 
orthopaedic problems leads to these problems being overlooked.   
 
A similar review highlighting orthopaedic disorders by Caird, Wills and Dormans  (2006) looked at 
the role of the orthopaedic surgeon. In comparison to Jacobsen and Hansson they emphasised AAI 
and hip instability but also included a short paragraph on arthropathy of DS. However their 
description of this arthropathy in DS is based only on Olson et al (1990) when there were other 
published articles available to reference (Yancey et al, 1984; Padmakumar, 2002).  
 
Dugdale and Renshaw (1986) researched patellofemoral instability. They examined 210 
institutionalised patients with DS and reviewed the notes of all patients with DS hospitalised in a 
28 year period at a children’s hospital in Connecticut. Seven children were identified with a 
reported patellofemoral instability from hospital notes and interviewed with their families. They 
were not included in the analysis for prevalence as could not be considered a random group. The 
remaining 210 institutionalised patients (132 male) were examined for instability and 22.4% were 
found to have bilateral patellofemoral instability which was a similar finding to a previous study by 
Diamond, Lynne and Sigman (1981). Dugdale and Renshaw concluded that patellofemoral 
instability can be common in DS but commented on the fact that it is often overlooked. 
 
2.8 Pain response in DS 
 
Lind , Vuorenkoski, Rosberg, Partanen and Wasz-Höckert performed varied studies into pain 
stimuli in infants including a study in infants with DS (1970).  Forty seven children were identified 
from two hospitals in Sweden. Seventeen were excluded from the study; three failed to give a cry 
response despite repeated stimuli and 14 due to an underlying medical condition. The pain cries of 
the 30 remaining children were compared with 120 infants without DS. Eight attributes of cry were 
examined; latency, length, minimum pitch, maximum pitch, flat melody form, bi-phonation, 
stuttering voice and nasality. Seven of the eight attributes showed a statistical difference (p<0.001) 
with latency showing a p value of 0.05. Lind et al showed that the pitch of the cry is lower in DS 
but also acknowledged that this change in pitch can be altered in infants with other serious 
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diseases, not only in infants with DS. Pitch alone is not the only attribute in infants DS and other 
attributes alongside pitch determine the differences.  Lind et al did not mention response time in 
early infancy but discussed that many of the children over a year produced no response to pain such 
as grimacing or limb movement showing reduced cry response. They also commented that, at this 
stage, the cry was particularly short.  
 
The authors direct the reader to previous studies for methods and anylysis rather than describe how 
they collected the data in this paper. This leads to the results and discussion appearing disjointed 
and confusing without access to these studies as they were not available within the literature search.  
 
Hennequin et al (2000) looked at pain expression and localisation of stimulus in DS. This was 
based on the conclusion of previous studies by Lind et al (1970) and Biersdorff (1994) which 
suggested that patients with learning difficulties displayed behaviour suggesting a decreased 
response to pain. Hennequin et al identified 26 people with DS and 75 controls. They were 
recruited based on attendance at a dental unit within a period of 12 months. Two clinicians were 
trained and calibrated to apply cold stimulus in the form of ice cubes to the skin until sensation of 
pain was first felt and then cold stimulus applied to different points to establish localisation.   
 
The study showed that the individuals with DS took longer to express pain and made more  
errors in localising the stimulus. In the test showing length of time to report pain a Mann-Whitney 
test showed a significant difference between the individuals with DS and the controls (p=0.0005). 
In the localisation test a Fisher’s exact test showed a significant difference for localising cold 
stimulus on the hand (p=0.0005), the face (p=0.0005) and the mouth (p=0.0005). The authors 
acknowledged that the study was a pilot and further investigations should be carried out. However, 
despite the small sample size of DS patients, this is a thorough and well explained project.  
 
In letters to the Lancet in 2001 both Jessop and Brandt wrote to comment on the paper by 
Hennequin et al (2000). Jessop suggested that the decreased perception of pain may be due to 
raised opioid peptides in the frontal cortex of this group of individuals. Brandt suggested that there 
might be a link between Down’s syndrome and impaired peripheral somatosensory nerve function.  
 
The literature suggests that there may be reduced perception of pain in children with Down’s 
syndrome (Lind et al, 1970; Martínez-Cué et al, 1999; Hennequin et al, 2000) which concurs with 
the clinical observations of the RHSC Yorkhill pilot study that children with DS do not feel or 
express the same level of pain as the general population (Cruikshank et al, 2008). The mean delay 
from symptom onset to the diagnosis of arthritis in children with DS was 2.9 years compared to 0.3 
years in JIA and a factor in the delay was felt to be the lack of expression of pain (Cruikshank et al, 
2008). A number of these patients had not complained of joint pain when seen by a health 
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professional. It is also interesting to note that, in the 25 cases described by Yancey et al (1984), 
Olson et al (1990) and Juj et al (2009), only two of the children presented complaining of pain 
whereas the majority of patients presenting with JIA in the general population will complain of 
pain.  
 
2.9 Growth retardation 
 
Growth retardation and delayed bone age are important in MSK development and related disorders. 
 
There have been numerous studies into growth retardation in children with DS. Cronk, Crocker, 
Pueschel, Shea, Zackai et al (1988) examined 730 children with DS aged from one month to 18 
years to create DS specific growth charts in America. The children were divided into five groups 
which makes the study more robust as each group had a different age range and were measured at 
different intervals. Comparison of the five groups showed no statistical significance so all results 
were analysed together. There were no exclusions but complicating medical disorders were 
recorded because of their potential impact on growth.  
 
Myrelid, Gustafsson, Olars  and Annerén  (2002) carried out a similar study to create DS specific 
growth charts in Swedish children. They examined 354 children between birth and 18 years 
monthly until aged 2, quarterly until aged 3 and thereafter annually. Their only exclusion was 
individuals who had received growth hormone previously. Their results showed that children with 
DS were shorter in stature than the general population (-2.5 SD, Swedish standard). Myrelid et al 
(2002) compared their results with Cronk et al (1988) commenting on the fact that there were 
differences between the mean final heights of the Swedish and American children which they 
couldn’t explain but which could be down to ethnic differences or size of the study population.  
 
Myrelid et al and Cronk et al both agreed that there is a reduction in height in children with DS 
compared with the general population. Both studies correlated that the period of the largest 
impairment in growth velocity is between six months and three years. Similar studies carried out by 
Cremers, van der Tweel, Boersma, Wit and Zonderland (1996) in Dutch children and Kimura, 
Tachibana, Imaizumi, Kurosawa and Kuroki (2003) in Japanese children showed comparable 
results indicating a trend and, therefore, more validity to the results. 
 
Various studies looked at growth hormone (GH) deficiency in children with DS and the use of GH 
to improve height outcome in these children. Castells, Torrado, Bastian and Wisniewski (1992) 
carried out a study on 20 children with DS measuring at serum GH levels over 24 hours. Serum GH 
response to levodopa and clonidine stimulation was also recorded. Results showed reduced GH 
concentration in response to levodopa and clonidine stimulation. A study with a control group is 
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required for more conclusive results, but this study suggests growth hormone deficiency may be an 
important factor in growth retardation in DS. 
 
Castells, Beaulieu, Torrado, Wisniewski, Zarny and Gelato (1996) followed the 1992 study up with 
a further study this time including a control group. Their aim was to determine whether 
hypothalamic or pituitary dysfunction was the cause of growth retardation. Three groups were 
involved. These were a group of 14 children with DS, a group of seven children who were small in 
stature but had normal GH serum levels and a group of 25 children with normal heights and 
weights. The results showed no significant difference in GH levels following GH releasing 
hormone between the groups but a significantly lower response to levodopa and clonidine in the 
DS group. Maximum response to levodopa stimulation in controls was 12.3±11.1 and in the 
children with DS was 5.7±6.3; p<0.0003). These results suggested a hypothalamic link to reduced 
GH levels in DS. Although the number of children with DS is smaller in this study compared to the 
1992 study, these results are more conclusive due to a comparison with control groups. Both 
studies showed retardation in bone age in the children with DS. 
 
2.10 Podiatric disorders and gait 
 
Specific foot problems are described in DS such as pes planus, syndactyly and hallux valgus and, 
due to the frequency of other severe pathologies in DS, these problems can be overlooked in their 
importance. (Concolino et al, 2006).  
 
Prasher, Robinson, Krishnan and Chung (1995) performed a podiatric exam on three groups of 
children, also examining footwear. The first group was 50 children (29 males) with DS, the second 
was 50 children (32 males) with a learning disability (LD) other than DS and the third group of 50 
children (20 males) had no learning disability. This study showed an increase in foot pathology 
within the DS group and the non DS group with LD compared to the non LD group (p<0.05). The 
DS group had greater incidence of pes planus (58% versus 20% for the other groups). Footwear 
was generally good in all the groups although the children with an LD were more likely to wear ill 
fitting footwear. This study, however, displayed drawbacks in that the children were selected by 
their school so recruitment may have been biased but it does highlight the need for correct footwear 
and vigilance regarding pedal problems to prevent the development of more serious conditions.  
 
Concolino, Pasquzzi, Capalbo, Sinopoli and Strisciuglio (2006) examined 50 children (19 males) 
with DS and a control group of 100 children (32 males) without DS in Italy. Full orthopaedic 
examination of the lower limbs and podiatric examination was carried out by the authors. Results 
showed an increased incidence of bony deformities of the forefoot in the children with DS (90% 
compared to 10% in the controls) and also an increase in joint laxity (20% showed severe laxity 
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and 80% moderate laxity compared to 20% showing slight laxity and 80% with no laxity in the 
control group). It was concluded that podiatric examination is important when these children are 
reviewed as early detection and treatment will improve quality of life. This study showed a very 
thorough examination of each child and concluded that podiatric exam is an important inclusion as 
treating pedal problems can improve posture and improve quality of life for children with DS.  
 
A number of studies have investigated gait and posture in children with DS (Shumway-Cook et al, 
1985; Selby-Silverstein et al, 2001; Galli et al, 2008; Chang et al, 2009; Rigoldi et al, 2010).   
Selby-Silverstein, Hillstrom and Palisano (2001) concentrated on the effect that using foot orthoses 
(FO) had on posture and gait in DS. The investigator examined 16 children with DS and 10 
controls. The DS children were examined at three separate visits where they were casted for FOs at 
the first, examined in sneakers at the second and then examined with sneakers and FOs at the third. 
The control children were examined twice and not casted for FOs. The mean resting stance position 
in children with DS changed from 11 degrees everted barefoot to 3 degrees everted in FOs (73% 
change; p<0.001) and the mean transverse plane foot angle for children with DS 7 degrees walking 
in sneakers and 0 degrees walking in sneakers and orthosis (p<0.001). This study is of a very small 
group of children and may benefit from a higher population with a wider range across the learning 
disability spectrum. A larger number may be more conclusive about the appropriate use of FOs. 
The authors concluded that their findings warranted further investigation particularly around the 
use of FOs affecting the development of external tibial torsion and the effect on the knees. They 
acknowledged that, to ensure the appropriate alignment, foot orthoses and shoes should be 
evaluated correctly before provided to the wearer. 
 
Galli, Rigoldi, Brunner, Virji-Babul and Giorgio (2008) and Rigoldi, Galli and Albertini (2010) 
both examined gait development and pattern in children with DS in Rome, with the latter also 
examining joint stiffness. Both studies carried out kinetic studies using a gait walkway. Galli et al 
examined 98 children with DS and 30 control children and Rigoldi et al followed 32 children with 
DS and studied them in childhood, teenage years and adulthood. Both studies found that the 
children with DS showed a statistically significant lower step length than controls (p<0.05 in both 
studies), statistically significant lower velocity (p<0.05 in both studies) and Rigoldi et al also 
showed a statistically signficant higher step width (p<0.05). Both studies concluded that reduced 
step length and lower velocity are due to compensation to increase stability while walking as 
movement is unstable due to lax ligaments and hypotonia. 
 
Chang, Kubo and Ulrich (2009) studied development of walking from walking onset over a six 
month period in children with DS compared to children with typical development.  They examined 
eight toddlers with DS (three female) and eight toddlers with typical development (four females) 
walking across a gait walkway. Although their main focus was muscle burst duration and 
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frequency as well as timing, they also found that the toddlers with DS showed a statistically 
significant higher step width and lower velocity (p<0.05). This correlates with Galli et al (2008) 
and Rigoldi et al (2010). The step length variation was not consistent over this six month period. 
This may be because of the age and stage of the children and the fact that it is a very small study of 
eight children in each group. Rigoldi et al (2008) do not mention the age range of the children 
examined but the youngest child examined by Galli et al was five years. This suggests that a 
longitudinal study covering a number of years from walking onset with a higher number of children 
may produce data to show if step length decreases consistently over a period of time. 
 
2.11 General care and screening 
 
Pueschel , Annerén , Durlach , Flores , Sustrová  and Verma  (1995) published a committee report 
for the International League of Societies for Persons with Mental Handicap on guidelines for the 
optimal care of people with DS. They advised when screening by health professionals for particular 
medical conditions related to Down’s syndrome should be carried out, divided into four age 
categories – neonatal, infancy, childhood and adolescence and adulthood. Each condition is 
discussed fairly briefly as they acknowledge that it is not possible to discuss all related conditions 
within the paper. However, some of the screening is advised into adulthood, particularly weight, 
eye screening, hearing exam and thyroid screening supporting the reasoning that people with DS 
should have regular assessment. In relation to MSK disorders, atlantoaxial, hip and patellar 
instability, foot disorders and scoliosis are mentioned within the screening. There is no mention of 
arthritis in DS. 
 
Roizen and Patterson (2003) discussed the genetics, assessment and management of DS. They 
divided the various health problems associated with DS into three categories – those to prevent; 
those to monitor and those that require vigilance. Arthritis was in the last category. They agreed 
that arthritis occurs more frequently in the Down’s population ‘but not frequently enough to 
warrant routine monitoring procedures’ (Roizin and Patterson, 2003). They mentioned the delay to 
diagnosis and used it as the reason why arthritis requires vigilance. However, the evidence base 
behind their comments is weak due to the use of only two references (Olson et al, 1990; Ihnat et al, 
1993) despite others being available (Yancey et al, 1984; Padmakumar et al, 2002). Incorporating a 
routine monitoring procedure would help diagnose multiple MSK problems within this population. 
 
Harrison, Plant  and Berry  investigated regular screening for people with learning disabilities 
within a primary care centre. All patients with learning disabilities were identified and records 
checked for last contact with a health professional. They discovered that only 22% of the 60 
patients identified had attended in the last year. One patient hadn’t attended for 14 years. Invitation 
letters were sent to invite the patients in for screening and by the end of the year 92% of the 60 
47 
 
 
patients had attended for health screening. This appears to have been a very well run and executed 
study. The improvement in numbers for screening was extremely high. The authors took the 
patients’ individual needs into consideration as well as general screening and also took time to 
discuss and consider the needs of the carers also. They also offered a choice of clinic or home for 
the assessment to allow flexibility for the carers. 
 
Weijerman and de Winter (2010) investigated the care of children with DS. They also discussed the 
background to DS and assessment involved and the different related health problems. Arthritis is 
discussed under the orthopaedic heading in one sentence that a rare arthropathy can develop in 
children with DS.  
 
2.12 MSK screening in DS 
 
It is obvious that MSK disorders are still not considered important within the care or screening of 
children with DS. The papers, looking specifically at arthritis in DS, concur that arthritis is 
misdiagnosed and these delays can lead to significant damage to the joints and, therefore, a great 
reduction in mobility. This then makes a significant impact on the quality of life of these children.  
 
An MSK exam can be done quickly and efficiently following the pGALS (paediatric gait arms legs 
spine) (Figure 2.1) criteria. GALS is a screening process suggested by Doherty et al (1992) as a 
practical tool for health professionals to follow. Foster et al (2006) revised this tool to create a 
similar process for children.  
 
Goff et al (2010) researched the addition of pGALS to routine assessment on presentation at an 
acute paediatric unit. Presenting complaint, diagnosis, time taken in completing pGALS and a 
patient scale on acceptability were recorded. The examining doctor had no previous rheumatology 
training. He was given the video teaching tool of pGALS being performed and then observed in the 
rheumatology clinic performing the assessment prior to the study. The authors conclude that using 
pGALS does not make a large impact on general assessment and can be carried out in just three to 
four minutes which is a favourable comparison with the rheumatology specialists. This means it 
can be carried out completely at initial assessment. 
  
Annual reviews are recommended for children with DS due to their greater health requirements. 
(McGrath, 2010) At present these reviews are not mandatory but are generally carried out. The 
importance of this screening is summed up by a parent that took part in the study carried out by 
Harrison et al (2005). An elderly carer claimed, ‘I have been waiting years for my son to be called 
for the type of screening I take for granted’ (Harrison et al, 2005). 
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There are many various health problems linked to DS making screening a difficult and, possibly, 
prolonged exercise. However, the addition of an MSK screen should not extend this greatly and its 
addition is extremely important in this group of patients.  This will lead to earlier diagnosis, 
reduced incidence of joint damage, improved prognosis and continued quality of life for these 
children. 
 
2.13 Summary: 
 
A wide range of MSK problems occur in DS during childhood.  These have been identified in a 
significant body of literature over a number of years, however their true prevalence in the 
population is not known, nor the impact in terms of disability.  This study aims to screen a 
population of children under the age of 16 years with DS to identify the prevalence of MSK 
problems, to identify their nature and impact on this group of children. 
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Figure 2.1  pGALS exam (Foster and Cabral, 2006) 
 
 
 
 
 
 
pGALS Musculoskeletal Screening Examination 
 
Screening Questions: 
Do you have any pain or stiffness in your joints, muscles or your back? 
Do you have any difficulty getting yourself dressed without any help? 
Do you have any difficulty going up and down stairs? 
Gait: 
Observe the child walking 
‘Walk on tip-toes/walk on your heels’ 
Arms: 
‘Put your hands out in front of you’ 
‘Turn your hands over and make a fist’ 
‘Touch the tips of your fingers’ 
Squeeze metacarpal joints 
‘put your hands together/put your hands back to back’ 
‘reach up and touch the sky’ 
‘look at the ceiling’ 
‘put your hands behind your neck’ 
Legs: 
Feel for effusion at the knee 
Active movement of knees and feel for crepitus 
Passive movement ( full flexion, internal and external rotation) of hip 
Spine: 
‘Open your mouth and put three( child’s own) fingers in your mouth’ 
Lateral flexion of cervical spine ‘try and touch your shoulder with your ear’ 
Observe spine from behind 
‘Can you bend and touch your toes?’-observe curve of spine from side and behind 
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CHAPTER 3 
 
MATERIALS AND METHODOLOGY 
 
This chapter will look at the evidence base behind the equipment and methods used in this study. 
This will include ethics in medical research and the examinations, measurements and equipment 
involved in the study. 
 
3.1 Ethics 
 
This study submitted an ethics application which was approved by the West of Scotland Research 
Ethics Committee (Appendix 1). Medical research must be approved by a medical ethics committee 
prior to commencement. Medical ethics is in place to protect the participants and those conducting 
the study. Ethical committees were created to allow assessment of research proposals from 
different viewpoints. Committees consist of representatives from clinical, research and community 
groups (Davidson and O’Brien, 2009). Community involvement is particularly important as these 
representatives are likely to digest the information in a similar manner to the patients.  
 
Literature on history of research shows experiments performed over centuries with no regard for 
the subjects. Queen Cleopatra carried out research into the development time period of male and 
female foetuses. This was done by the insemination of servants who were then executed and the 
foetus examined post mortem for development status (Kottek, 1981; Cohen, 1990). In 1796 
Edward Jenner exposed a boy to the cowpox virus and then innoculated him with smallpox to see if 
it would develop (Gross and Sepkowitz, 1998) and numerous medical experiments were carried out 
by the Nazis during World War II in the concentration camps. Many of these experiments resulted 
in the torture and, in the majority of cases, death of the prisoners involved (Cohen, 1990). 
 
Following the Nazi trial at Nuremburg in 1947, the Nuremburg code was developed to protect 
people from unethical research and, most importantly, introduced the necessity for informed 
consent (http://ohsr.od.nih.gov/guidelines/nuremburg.html). In 1964 the Declaration of Helsinki 
was developed by the World Medical Association to provide ethical principles for research 
involving human subjects (www.wma.net). This is regularly updated with the most recent update in 
2008.  
 
In 1979 Beauchamp and Childress formulated the four main principles in ethics. These are now the 
standard model for teaching ethics. (Gillon, 1994; Lawson, 2011) 
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3.1.1 Autonomy 
 
Autonomy describes each individual’s ability to make their own decisions which should be 
respected in research. All relevant information involved in the proposed research should be given 
to the individual to allow them to make a full, informed decision about participation. Respecting 
autonomy also includes ensuring good communication, maintaining confidentiality and avoiding 
deception.   
  
3.1.2 Beneficence and non-maleficence 
 
The principles of beneficence and non-maleficence describe decisions made in the best interests of 
each individual. Beneficence describes a decision that will cause no harm whereas non-maleficence 
describes decision making intended not to cause harm to the individual despite possible risks 
involved or where the benefits surpass any involved risk.  
 
3.1.3 Justice 
 
The principle of justice involves treating all individuals in an equal manner and allowing fair 
distribution of resources. In medical care this means allowing each individual the same access to 
treatment and relevant information although treatment patterns will be different for each person. In 
research it means ensuring each participant receives the same information regarding the study, the 
same experience throughout the study and the same opportunities that result from the research. 
 
These principles all combine in individual decision making as each can conflict. An individual can 
be given all information regarding treatment that is in their best interest which may or may not 
have side effects (beneficence and non-maleficence) but they may decide to refuse the treatment 
despite having all the information and, if considered competent, their autonomy in making that 
decision must be respected. 
Nurses involved in research are bound by the Nursing and Midwifery Council Code of Professional 
Conduct which includes treating the client as an individual, respecting their dignity and upholding 
their right to be fully involved in decisions about their care (www.nmc.org/Nurses-and-
midwives/The-code/The-code-in-full). It also states that you must respect and support people's 
rights to accept or decline treatment and care. All these take the principles of ethics into account. 
The nursing code of conduct was originally developed by the United Kingdom Central Council for 
Nursing and Midwifery in 1983 and is reviewed regularly (www.nmc.org).  
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3.1.4 Informed consent 
 
All relevant information must be given to participants in medical research to allow them to make a 
full informed decision to consent to taking part. Research cannot proceed without participants 
signing a consent form. The Nuremburg Code states ‘The voluntary consent of the human subject is 
absolutely essential’ (http://ohsr.od.nih.gov/guidelines/nuremburg.html). Participants cannot be 
coerced into signing consent and must be allowed time to consider all the information prior to 
consent being signed and the research commenced. 
 
3.1.5 Ethics in research involving children 
 
With respect to this study our main consideration was that it required consent for children being 
involved and, in particular, the ethical issues surrounding research involving individuals with 
learning disabilities and this was examined fully. Several issues have to be considered in these 
cases such as whether the individual is able to give informed consent, how their level of 
understanding can be tested and, even if unable to give informed consent, can they give assent to 
the research.  
 
 Research involving children is given more ethical consideration to ensure the child is not being 
exploited or coerced into the research. Ethics committees may scrutinise paediatric research 
projects more closely than an adult project (Davidson and O’Brien, 2009). At present parental 
consent is required for children up to the age of 16. If the child is considered mature enough to 
understand the information and make an informed decision, they may sign assent as an agreement 
to take part, although parental consent is still required. Information sheets should, therefore, be 
designed to allow an understanding level in accordance with the age of the child in addition to 
parent information. It is important to respect the child by involving them in the decisions 
(Davidson and O’Brien, 2009). Information sheets for this study were designed using three levels 
of understanding for the children as well as information sheets for parents. The parents were then 
given the decision to choose which level of information sheet was appropriate for their child. 
(Appendix 2) 
 
In 2002 the Royal College of Paediatrics and Child Health (RCPCH) outlined six key principles 
(Table 3.1) when revising the 1992 document on guidance on the conduct of medical research with 
children (Neill, 2005).  
 
A decision was made to involve children between the ages of two and fifteen in this study as, over 
16, the child is considered an adult with learning disabilities at which point the ethical 
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considerations become very complicated, particularly in the issue of informed consent. The adult 
has to be deemed incompetent to make an informed decision before the parent or surrogate makes 
the decision for them. The surrogate must fully consider the benefits and risks to the participant 
before signing consent on their behalf. Researchers prefer not to use surrogates unless absolutely 
necessary as it is considered imappropriate by many and would require a strong justification for the 
ethics committee (Wiles et al, 2005). Even if surrogate consent has been given, the individual’s 
wishes still have to be considered as their rights to decide to participate requires to be recognised 
(Lewis and Porter, 2004). 
 
Although parental consent was given for the study, the rights of all the children involved were 
considered at all times as they were given the right to refuse to allow any examination involved in 
the study visit. 
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Figure 3.1: Six principles for research involving children; RCPH Ethics Advisory Committee, 2000 
(Neill, 2005) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Key Principles 
 
1. Research involving children is important to benefit all children and should be conducted in an 
ethical manner. 
2. Children are not small adults; they have an additional unique set of interests. 
3. Research on children should only be done if comparable research cannot be done on adults. 
4. Research not of direct benefit to the child is not necessarily unethical or illegal. 
5. All proposals involving medical research on children should be referred to a research ethics 
committee. 
6. Legally valid consent should be obtained from the child, parent or guardian as appropriate. 
Parental consent for school children should also have the child’s agreement. 
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3.2 Subject identification and recruitment 
 
The Glasgow thyroid register and the community paediatrician’s register were assessed to identify 
children with Down’s syndrome aged between 2 and 15 resident in Glasgow. 147 children were 
identified from these registers. Five children were excluded due to serious illness and 142 children 
invited to participate in the study. Study packs including an invitation letter and parent’s 
information sheet were sent out. These packs also included three separate children’s information 
sheets which aimed at three different levels of understanding to allow the parents to decide which 
sheet was most appropriate for their child to understand. These were then followed up with a phone 
call. To avoid parents feeling they were being harassed, it was considered a non response after 
three unsuccessful contact attempts.  
 
3.3 Inclusion criteria 
 
Children identified to have DS and resident in Glasgow and aged between two and sixteen years. 
 
3.4 Exclusion criteria 
 
The exclusion criteria were: 
1. Children with co-morbidities and too unwell to take part or considered unsuitable by the 
community paediatrician or GP.  
2. Children under two or over sixteen.  
3. Children who declined or were unable to participate. 
 
3.5 Study visit examinations 
 
This study was designed to examine a variety of measurements related to MSK disorders and 
anthropometric measurements in Down’s syndrome including a full joint examination assessing for 
joint limitation, hypermobility and evidence of synovitis, assessment of entheses and podiatric 
examination. Height, weight, head circumference and arm span were measured and questionnaires 
were completed by the parents. 
 
Participants were invited to attend a one off study visit at their community paediatrician annual 
review appointment, at RHSC Yorkhill or as a home visit to allow flexibility and choice. All study 
participants were examined by the same research nurse and the same podiatrist to allow for 
consistency and the same equipment was used for each study visit. Each study visit lasted 
approximately 45-60 minutes depending on the ease of co-operation of individual children. 
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3.5.1 MSK  examination 
 
The main component within the study visit was a complete MSK and podiatric examination of each 
child. An adapted version of the pREMS (Paediatric Regional Examination of the Musculoskeletal 
System) assessment (Appendix 3), developed by Foster et al (2011) from the adult REMS 
assessment developed by Coady et al (2004), suitable for this population of children was carried 
out during the study visit. 
 
The shorter pGALS method of examination (Figure 2.1) has been shown to be sensitive and 
acceptable to school age children and parents (Foster et al, 2006). However, it is a screening tool to 
identify active and limited joints and the pREMS gives a more thorough examination of each 
anatomic region although younger children may require a different approach depending on 
compliance. This was more suitable for identifying hypermobile joints. Foster et al (2011) 
developed pREMS to work with pGALS as a thorough method of examination with an aim to 
incorporate both assessments into routine practice to improve outcome. 
 
For this study, examination did not completely adhere to the full pREMS procedure due to the 
compliance of children with learning difficulties. Each child was considered on an individual basis 
and examined accordingly. Children who were non compliant with certain parts of the examination 
had a reduced exam carried out to their level of tolerance. Often observation of children’s 
functioning was supportive evidence, for example sitting posture with feet behind head strongly 
suggested hypermobile hips even if examination was not possible. In general the children were 
very compliant with the study process. pREMS was shown to be a reliable method of examination 
and well tolerated as a screening tool for MSK problems in this population. 
 
MSK examination was carried out to determine the presence of arthritis, hypermobility, enthesitis, 
signs of joint instability, scoliosis of the spine, limb length discrepancy and genu valgum (knock 
knees). 
 
3.5.2 Arthritis 
 
All joints were examined for signs of arthritis including pain, heat, swelling and limitation of 
movement. The number of active and limited joints found on examination was noted as per the core 
outcome variables for arthritis disease activity. The core outcome variables incorporate patient or 
parent global assessment, physician’s global assessment, the childhood health assessment 
questionnaire and the number of active and limited joints present on examination (Giannini et al, 
1997; Gardner-Medwin and Southwood, 2005).  
 
57 
 
 
‘The Childhood Health Assessment Questionnaire (CHAQ) (Appendix 4)  is a disease specific 
heath instrument that measures functional ability in daily living activities in children with juvenile 
idiopathic arthritis’ (Nugent et al, 2001). This questionnaire asks how the child’s activities have 
been limited by their condition over the last seven days. Parents are asked to complete the child 
form for children up to 11 years and the child completes the adolescent form (Appendix 5) after 
this age. For this study level of understanding and learning disability was ascertained and parents 
asked to complete the child form for all children even if they were over 11 if they felt it more 
appropriate for their child’s level of learning disability. It has been shown to be reliable and 
sensitive in measuring how children function with arthritis (Dempster et al, 2001).  
 
The Child Health Questionnaire (CHQ) has been designed to assess the well being of children with 
underlying disease (Nugent et al, 2001). This questionnaire asks how the child’s illness affects 
them in different areas such as physical, emotional, general well being and also how it affects the 
family as a whole. (Appendix 6) 
 
The CHAQ also incorporates a parent/child and physician global assessment. This involves the 
completion of an analogue scale 10cm long to determine level of pain and wellness over the last 7 
days. 
 
3.5.3 Hypermobility 
 
The number of hypermobile joints was also recorded and general hypermobility was assessed by 
the use of the Beighton scoring system (Figure 3.2) and Brighton criteria (Figure 3.3).   
The Beighton scoring system shows limitations as it only includes 9 joints. Joint hypermobility 
syndrome is a complex condition to diagnose as there is no current gold standard in place for 
normal joint mobility (Remvig et al, 2007). Simmonds and Keer (2007) acknowledged that the 
Beighton score on its own has been criticised for only sampling a few joints but incorporating it 
into the Brighton criteria makes it stronger as it links joint hypermobility with other symptoms and 
characteristics of connective tissue laxity. 
Smits-Engelsman, Klerks and Kirby (2011) examined the use of the Beighton score in children and 
concluded that the Beighton score was a valid instrument to calculate generalised joint mobility in 
children but recommended increasing the threshold to 7/9 instead of 5 as they believed that having 
the threshold at 5/9 classified too many children as hypermobile incorrectly. 
Juul-Kristensen, Røgind, Jensen and Remvig (2007) showed that reproducibility for the Beighton 
tests and Brighton criteria was good ( kappa values mostly above 0.80 and 0.73 respectively) but 
suggested further research is required.  
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In a letter to the British Journal of Rheumatology Silman and Day (1987) wrote ‘we believe, 
however, it is preferable to measure the actual range of movement at one or more joint sites rather 
than relying on fairly arbitrary cut off  levels’. This was in response to a study comparing the mean 
Beighton scores in population groups. Silman and Day considered this inappropriate as individuals 
with the same Beighton score cannot be assumed to be the same in relation to their mobility.  
The Beighton scoring system was developed for epidemiological studies as opposed to a diagnostic 
test but is used in conjunction with the Brighton criteria to diagnose joint hypermobility syndrome. 
It has received criticism and researchers have attempted to create more updated systems but it 
remains the universal assessment for studies in hypermobility (Grahame 1990). The Beighton score 
still continues to be used today.  
The Beighton score has been used in previous population studies and we have used Clinch et al, 
2011 specifically to compare results which is described in Chapter 5.  
In this study the Beighton scores and Brighton criteria were used in conjunction with range of 
movement examination of all joints to provide a more complete assessment of the level of 
hypermobility of each child with the hypermobility of all joints being specifically charted to avoid 
incorrect assessment from the scoring systems alone.  
3.5.4 Enthesitis 
Enthesitis is inflammation at the site that a tendon, ligament, fascia or joint capsule is attached to 
the bone. Inflammation at these sites occurs in the related group of conditions known as 
seronegative arthropathies in adults,  which include ankylosing spondylitis (inflammation of the 
spinal column), psoriatic arthritis (arthritis related to psoriasis) and reactive arthritis (arthritis 
following infection) (McGonagle and Benjamin, 2009), and in JIA enthesitis related arthritis, but 
currently not psoriatic arthritis, as the classification stands, although in adult disease this 
association is well described . It can also include arthritis related to inflammatory bowel disease. 
Spondyloarthropathies are an adult group of inflammatory disorders that can all include 
inflammation of the spine and have a negative rheumatoid factor (Keat, 2008). They were first 
described as  associated with a positive HLAB27 (Human leucocyte antigen B27), 95% of 
ankylosing spondylitis and 75% of reactive arthritis cases are HLA B27 positive with lower 
percentages in psoriatic arthritis. A positive HLAB27 can also aid a diagnosis of early psoriatic 
arthritis (Stafford and Youssef, 2002). 
Only a certain number of entheses are routinely palpated and, in children, the commonest sites of 
enthesitis to be examined are the insertion points of the plantar fascia on the base of the foot and 
the Achilles tendon insertion at the heel (Gardner-Medwin and Southwood, 2005). The entheses 
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points are pressed to elicit signs of tenderness which indicates enthesistis and several scoring 
systems have been devised to assess this. (McGonagle and Benjamin, 2009). 
The scale used in the study is based on the Mander enthesis index where intensity of pain is graded 
on a 0-3 scale - 0 = no pain; 1=mild tenderness; 2=moderate tenderness; 3=wince or withdraw 
(Mander et al, 1987; Heuft-Dorenbosch et al, 2003).  This scale covered a 0-2 scale: 0=no pain; 
1=tender; 2= tender + grimace. (Appendix 7) 
3.5.5 Podiatric examination 
A foot examination standardised for the study was devised and carried out by a single consultant 
podiatrist, very experienced in paediatric podiatry, based on current examination standards and 
techniques (Goel and Watt, 2010) looking at foot type and posture, characteristics of the foot, shoe 
type, gait and nail conditions. (Appendix 8) All subjects were examined by the same researcher 
using the same methodology for each in order to maintain consistency. 
 
The main joint complexes in the foot were assessed physically for range of motion.  
 
Foot type was recorded as shape of the foot, foot length and arch height. Posture was examined in 
relaxed and dynamic stance. Gait was examined with particular attention to hypotonic gait, genu 
valgum or varum (knock knees or bow legs), pelvic tilt or limp. Any deformities were recorded and 
also skin changes. Examination of nails and entheses were included.  
 
Footwear was examined with regard to correct sizing, type and suitability of footwear, use of 
orthoses (eg insoles) and wear marks. Wear marks should correlate with foot posture during 
walking and can indicate any issues with gait such as walking with over pronation or over 
supination (feet rolling inwards or outwards). Incorrect footwear can lead to disorders such as flat 
feet, hallux valgus (bunions), toe deformities and calluses (Prasher et al, 1995; Menz and Morris, 
2005). 
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                      Figure 3.2: Beighton score (www.arthritisresearchuk.org) 
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REVISED DIAGNOSTIC CRITERIA FOR THE BENIGN JOINT 
HYPERMOBILITY SYNDROME (BJHS) 
   Major Criteria 
· A Beighton score of 4/9 or greater (either currently or historically)  
· Arthralgia for longer than 3 months in 4 or more joints  
Minor Criteria 
· A Beighton score of 1, 2 or 3/9 (0, 1, 2 or 3 if aged 50+)  
· Arthralgia (> 3 months) in one to three joints or back pain (> 3 months), 
spondylosis, spondylolysis/spondylolisthesis.  
· Dislocation/subluxation in more than one joint, or in one joint on more 
than one occasion.  
· Soft tissue rheumatism. > 3 lesions (e.g. epicondylitis, tenosynovitis, 
bursitis).  
· Marfanoid habitus (tall, slim, span/height ratio >1.03, upper: lower 
segment ratio less than 0.89, arachnodactyly [positive Steinberg/wrist signs].  
· Abnormal skin: striae, hyperextensibility, thin skin, papyraceous scarring.  
· Eye signs: drooping eyelids or myopia or antimongoloid slant.  
· Varicose veins or hernia or uterine/rectal prolapse.  
The BJHS is diagnosed in the presence two major criteria, or one major and two 
minor criteria, or four minor criteria. Two minor criteria will suffice where there is an 
unequivocally affected first-degree relative. 
BJHS is excluded by presence of Marfan or Ehlers-Danlos syndromes (other than 
the EDS Hypermobility type (formerly EDS III) as defined by the Ghent 1996 (8) 
and the Villefranche 1998 (9) criteria respectively). Criteria Major 1 and Minor 1 
are mutually exclusive as are Major 2 and Minor 2. 
 
           Figure  3.3: Brighton criteria (www.hypermobility.org) 
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3.5.6 Psoriasis and psoriatic arthritis 
 
The case series of children with DS arthritis (Cruickshanks et al, 2008) showed that the majority of 
the children displayed characteristics of psoriatic arthritis. PsA belongs to the group of 
spondyloarthropathies. Although linked to psoriasis, the child may not have any history of psoriasis 
or current psoriatic lesions. Joint symptoms can occur prior to any evidence of the skin condition 
appearing in approximately 15% of patients (Southwood et al, 1989; Duran-McKinster et al, 2000; 
Veale and Fitzgerald, 2002; Stoll et all, 2006; Leung and Lim, 2007; Taniguchi and Kamatani, 
2007; Stoll et al, 2008; Prignano et al, 2010).  
 
Parents were asked if the child had a history of psoriasis or if there was a family history of psoriasis 
in accordance with the ILAR (International League Against Rheumatism)  classification of 
psoriatic arthritis (Gardner-Medwin and Southwood, 2005) (Table 3.5) 
 
Other clinical features of PsA include nail changes such as pitting, ridging and onycholysis (Tudor, 
1976; Southwood et al, 1989; Duran-McKinster et al, 2000; Veale and Fitzgerald, 2002; Leung and 
Lim, 2007; Taniguchi and Kamatani, 2007; Maejima et al, 2010; Natarajan et al, 2010; Prignano et 
al, 2010). 
 
Nails were examined for the above conditions and presence recorded. Number of nail pits was also 
recorded.  
 
Fingers and toes were examined for dactylitis which is common in PsA. This appears as swelling of 
the entire digit, mainly caused by inflammation and swelling in the flexor tendon sheaths and is 
referred to as a sausage digit (Leung and Lim, 2007). This dactylitis has been observed regularly in 
children with psoriatic arthritis as compared to children with JIA and often without evidence of 
psoriasis (Stoll and Punaro, 2011). 
 
3.5.7 Spine 
 
The movement level of the lumbar spine was recorded using the modified Schober’s test. An 
anchor point is identified at the L5-S1 level of the lumbar spine (dimples of Venus), a 10cm mark 
above and a 5cm mark below are marked while the patient is upright. They are asked to bend 
forward and the measured segment should increase from 15cm to 21cm. (Gladman et al, 2004). 
Schober’s test is one of the clinical tests used in population studies examining lumbar mobility in 
ankylosing spondylitis (Macrae and Wright, 1969; Gran et al, 1985; Mitra et al, 2000) and is a 
quick test to carry out. However this test displays limitations in this study cohort as accuracy may 
have been affected by the children’s level of understanding and level of compliance. 
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3.5.8 Anthropometric measurements 
 
Standing and sitting height were measured using a Leicester Height measure. Sitting height was 
measured to establish trunk and leg length (Gerver and Bruin, 1995; Fredriks et al, 2005). The 
Leicester height measure was chosen due to its portability as it was easily carried to various 
locations where study visits were carried out. It is also relatively inexpensive and is comparable in 
accuracy as the more expensive models (Voss and Bailey, 1994).  
 
Weight and body composition including bioelectrical impedance analysis (BIA) were recorded 
using Tanita scales. This is measured in Ohms and works on the fact that lean muscle will act as a 
conductor of electricity due to the high level of water and electrolytes it contains as oppose to fat 
tissue. A higher impedance value is indicative of a higher amount of body fat. (www.tanita.com). 
The reproducibility of anthropometrical and BIA Tanita measurements of fat mass are comparable 
in children and are convenient for epidemiological studies ( Sun et al, 2003; Kettaneh et al, 2005) 
Because the Tanita scales use an electrical signal, it was checked that none of  the study 
participants had a pacemaker in situ due to the high risk of cardiovascular problems in this 
population. It was considered safer to avoid any risk that the electrical signal might have interfered 
with the function of the pacemaker. However it was also limited in this study cohort due to 
restlessness as the children have to stay still on the scales for a few seconds to obtain a BIA 
measurement. 
 
Head circumference and arm span were also measured as they are indicators of normal growth and 
development (Smith, 1981; Ishikawa et al, 1987; Hoey and Cox, 1990; Palmer et al, 1992; 
Mohanty et al, 2001; Gnanavel et al, 2007). Palmer, Cronk, Pueschel, Wisniewski, Laxova, 
Crocker and Pauli (1992) carried out a study to develop head circumference reference curves for 
children with DS. Their results showed that males and females with DS have parallel growth and 
that head growth velocity appears to be similar to that of the general population until 5-6 months of 
age. Gnanavel, Parkash, Vishnu, Ramachandra and Rajesh (2007) found decreased head 
circumference in children with Down’s syndrome from birth contradicting the findings of Palmer et 
al. Despite contradictions in results head circumference remains one of several useful indices of a 
child’s development and is commonly used to screen for macro or microcephaly as even small 
deviations from the normal could be related to various diseases (Ishikawa et al, 1987; Hoey and 
Cox, 1990; Palmer et al, 1992; Schienkiewitz et al, 2010). 
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3.5.9 Hypotonia 
 
There is no recognised standardised measure of hypotonia other than clinical judgement. Elements 
of the childhood myositis assessment scale (CMAS) were used as a crude proxy to assess 
weakness. Core muscle strength was estimated using the CMAS scale (Lovell et al, 1999). This 
scale determines ease of certain movements such as sitting to standing, steadiness on all fours, 
rolling from supine to prone and picking up from floor to determine presence of hypotonia.  A 
number of the measurements included in the CMAS score involved a measurement of duration.  
These measurements were removed from the analysis for the study due to the poor quality and 
uncertain value of the measurements due to the level of learning disability of the children and their 
ability to comply with the study measurements.  
 
The CMAS scale is a valid and reliable tool for assessing muscle strength and endurance in 
children (Lovell et al, 1999; Huber et al, 2004). It was developed by Lovell, Lindsley, Renebohm, 
Ballinger, Bowyer et al (1999) as a scoring system for juvenile idiopathic inflammatory 
myopathies, such as juvenile dermatomyositis, to complement manual muscle testing in 
determining the severity of muscle weakness. It aims to assess the degree of weakness in the 
proximal myopathy associated with dermatomyositis, but is much more sensitive to small changes 
than manual muscle testing. They compared the CMAS scores, in children with a myopathy, with 
the physician’s global assessments, manual muscle strength testing (which is unreliable in children 
under 5), creatine kinase levels and the Juvenile Arthritis Functional Assessment Report (JAFAR) 
scores, which is a functional assessment questionnaire, and concluded that the CMAS was a valid 
and reliable scoring system. CMAS scores from morning and afternoon showed P<0.001 and 
interrater reliability showed P<0.001 for each of the 14 items on the CMAS and for the overall 
score. However they did find that the scores did not correlate with the age at the time of evaluation 
(P=0.86).  
 
3.5.10 General 
 
These examinations were carried out to allow a complete evaluation of each child’s 
musculoskeletal system and development to assess for any underlying or undiagnosed issues.  The 
visit was also utilised as a chance to educate the parents on signs of joint problems such as heat, 
swelling and inflammation. They were also advised that change of movement could be a sign of 
possible joint issues such as change in gait or change in use of a joint.  
 
All the children involved in the study were offered a referral to a consultant rheumatologist as a 
follow up to the study visit. The study personnel understood that the study visit may raise some 
concerns in the parents who may then prefer an appointment to reassure them. For children who 
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displayed any limitation in joint movement, the parents were encouraged to attend the 
rheumatology clinic. Any parents who did not wish referral at that time were advised that they 
could contact the service at any point up to their child’s 18th birthday.  
 
The majority of the children who participated in the study were very compliant with the 
examinations carried out, with the less compliant tending to have a higher level of learning 
disability. The parents were all very keen to be involved with the study and learn more about their 
children’s joints making the study visits successful and enjoyable. 
 
3.6 Validity of measurements and  limitations 
 
The above examinations and measurement techniques are shown by literature to be valid and 
reliable tools in their own areas but this is the first population study of this kind within the DS 
population so there was no reference to aid whether they would be reliable within this group of 
children.  
 
The CMAS scoring system had to be amended prior to the study commencing as the aspects that 
included duration measurements were considered unsuitable for this group of children and, 
although, the majority of the children were compliant with the tests, the scoring of this was not 
useful to assess hypotonia. 
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CHAPTER 4 
 
FOCUS GROUPS 
 
4.1 Introduction 
 
Concerns arising from a pilot study carried out in The Royal Hospital for Sick Children (RHSC), 
Glasgow (Cruickshanks et al, 2008) about the delay in diagnosis of arthritis in DS led to a 
decision to run focus groups to identify any barriers to care for these children with regard to 
MSK disorders.   
 
Cruickshanks et al (2008) identified 10 children with DS arthritis who had attended the 
rheumatology department. A number of these children presented late despite numerous contacts 
with health professionals, including annual review by community paediatricians, regular contact 
with physiotherapists and school nurses and appointments with orthopaedic consultants. Figures 
showed a median age at symptom onset of 5.9 (2–13.3) years but a median age at diagnosis of 
8.1 (4.2–15.6) years. This corresponded with the median time from symptom onset to first 
paediatric rheumatology appointment of 2.9 (0.1–8.7) years in comparison with 0.3 (0.1-9.9) 
years for a comparable cohort of 325 children with JIA from the same general population. This 
delay contributed to very destructive disease at presentation and four of the children were non-
weight bearing at first appointment. This correlates with previous literature describing children 
presenting late with destructive disease (Olsen et al, 1990; Juj and Emery, 2009).  However the 
children in the RHSC pilot study responded well to modern standard treatment for JIA, which is 
in contrast to previous literature which commented that children with DS didn’t appear to 
respond to treatment (Yancey et al, 1984; Olsen et al, 1990). This may suggest modern 
treatments, including biologic agents,are more effective.  
 
The pilot study raised concerns that these children were attending multiple medical 
appointments but signs and symptoms of arthritis were not being recognised until significant 
joint damage had already occurred. It also suggested that these children were responding well to 
treatment, contrary to the current literature. 
 
On the basis of these concerns it was considered important to conduct focus groups with the 
following three groups.  
1. Parents of children, who had already been diagnosed with arthritis and were attending RHSC, 
to discover what their journey to diagnosis had involved and the length of time taken.  
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2. Community paediatricians who lead the care of children in the community with DS, 
particularly their annual reviews, and are the gatekeepers to other allied health professionals 
(AHP) and other services to determine knowledge of MSK disorders and assessments carried out 
in the DS population.  
3. Paediatric rheumatology specialists involved with the care of these children to ascertain their 
experiences of level of disease, late presentation, prognosis at presentation and also response to 
treatment. 
 
4.2 Case study  
 
A 15 year old boy was referred to the rheumatology department by orthopaedics at RHSC with 
marked crepitus in his knee asking if an intra-articular steroid would help. It was discovered on 
presentation that he had at least a five year history of joint complaints.  
 
· At age 10 he was referred to orthopaedics with ‘rather an odd gait’ but received no 
intervention at that point. 
· At age 12 he was referred to physio with flexion in his knee. He was then referred back to       
orthopaedics by general paediatrics with a marked lumbar lordosis, crepitus in his knees but 
displaying no apparent pain. His knees were x-rayed at that point. His walking became very 
limited and he was found to have a full flexion deformity in his right knee which was warm 
and synovitic. The x-rays were reported as being consistent with multiple epiphyseal 
dysplasia (MED) and his parents were advised that his mobility would deteriorate gradually. 
· At age 13 he was re-referred to physio as he complained of being tired walking short 
distances. 
· At age 14 his hips, knees and elbows were found to be restricted but he did not complain of 
pain. His knees were crepitus and his gait was described as awful. He was unable to walk 
short distances and was unable to partake in physical activities at school. His mother 
thought that he was in pain but was dismissed as over-anxious and advised that his 
symptoms were the natural progression of MED and he was referred back to physio. 
· At age 15 he was referred to rheumatology asking if an intra-articular steroid injection 
would help as his knee had been synovitic for some time with crepitus present  
 
 
All these investigation were valid for the complaints this child presented with but all the features 
of arthritis were not pulled together to make the correct diagnosis for him.  
 
On presentation at rheumatology this child was wheelchair bound. He was found to have 
widespread polyarthritis with florid synovitis and widespread hypermobility and he presented 
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with extensive joint damage. His gait was dreadful, he had fixed flexion deformities and 
swelling in both knees (Picture 4.1 and 4.2), had restricted elbows, shoulders, wrists, neck and 
temporomandibular joints and subluxation at the wrists (Pictures 4.3). He was also found not to 
vocalise pain, but had obviously adapted his movement to minimize pain. 
 
This boy responded well to intra-articular and oral steroids and, despite side effects to initial 
disease modifying rheumatology drugs he responded well to treatment and was able to walk 
again fairly quickly. This boy is continuing to respond quite well to treatment but is limited in 
function due to joint damage sustained prior to treatment commencing. He still does not 
complain of pain and has described his joints as feeling ticklish. 
 
This delay to correct diagnosis caused concern regarding knowledge of MSK disorders in this 
population of children within other health professionals as particular signs and symptoms of 
arthritis such as complaints of pain may not be evident. However, in this case, signs of arthritis 
such as synovitis and crepitus were overlooked or misdiagnosed. If this boy had been referred to 
rheumatology much sooner his prognosis and outcome would have been much improved. 
 
This case study in conjunction with the concerns raised in the pilot study led to the decision to 
run these focus groups to establish level of joint damage and concerns at rheumatology 
presentation and level of knowledge of MSK disorders within the community and how this may 
be a barrier to early diagnosis.  
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 Picture 4.1 Swelling and deformity shown in front of knees in DS child with delayed diagnosis 
        of arthritis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture 4.2: Swelling and deformity shown in back of knees in DS child with delayed diagnosis 
       of arthritis 
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Picture 4.3: Wrist deformity and swelling in hands shown in DS child with delayed diagnosis of  
        arthritis 
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4.3 Methods 
 
4.3.1 Focus group planning 
 
It was planned to hold all three focus groups within RHSC Yorkhill. It was known that the 
community paediatricians and paediatric rheumatology specialists held regular educational 
meetings and each group was approached through a convener to organise the focus group during 
one of their meetings. Subjects were given information and signed consent forms agreeing to 
being recorded.  It was planned to approach the parents and arrange a convenient and suitable 
time for those happy to participate to attend RHSC Yorkhill. 
 
The topics for each group were formulated from discussions around the literature and the pilot 
study, from which the facilitator and supervisor derived a panel of four open ended questions 
given in the sections below… 
 
The planned analysis by the facilitator was around themes highlighted manually within the 
transcription and extracting relevant quotes for the discussion. 
 
4.3.2 Subject recruitment: 
 
Three focus groups were planned to take participants from three select groups: parents of 
children with DS who had developed arthritis who already attended the rheumatology 
department at RHSC, Glasgow; a group of community paediatricians who provided annual 
review of children with DS; and a group of paediatric rheumatology specialists with experience 
of the arthritis associated with DS.  
 
Ethics were obtained for the focus groups and participants were invited to take part.  
 
Parents or guardians of children with DS who already attended the rheumatology department at 
RHSC were identified through the rheumatology department and contacted by telephone to ask 
if they would be happy to participate and the telephone call followed up with the information 
sheets and invitation letter.  
 
The community paediatricians were identified through the education meeting facilitator and 
invited by email to participate in the focus group as part of an educational meeting. The 
community paediatrician focus group was carried out at RHSC Yorkhill, was facilitated by the 
author and lasted approximately 60 minutes. It was audio recorded and minuted by an 
administrator. The transcription was analysed by the author, themes extracted manually and 
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relevant quotes selected. Participants had given their consent to being recorded. This was a large 
group consisting of 20 consultant community paediatricians and associated registrars.   
 
The rheumatology specialists were identified through the rheumatology department at RHSC 
Yorkhill and invited by email to participate in the focus group as part of an educational meeting. 
Participants gave their consent to be interviewed and recorded. The paediatric rheumatology 
specialists’ focus group was carried out at RHSC, Yorkhill, was facilitated by the author and 
lasted approximately 60 minutes. It was audio recorded, transcribed verbatim and then analysed 
by the author, themes extracted manually and relevant quotes selected. Participants gave their 
consent to be recorded. 
 
Key open questions were identified prior to the sessions.  Focus groups were recorded and 
transcribed.  The author facilitated all focus groups.  
 
4.4 Parents  
 
4.4.1  Inclusion criteria 
 
Parents or guardians of children with DS attending the rheumatology department at RHSC, 
Glasgow 
 
4.4.2  Exclusion criteria 
 
Parents or guardians of children with DS not already attending rheumatology.  
Parents or guardians of study participants. 
 
4.4.3 Questions 
 
The intended questions for the parents’ focus group were to ask about any delays from symptom 
onset to attending paediatric rheumatology and what were their experiences within the health 
care setting. 
 
4.4.4  Results 
 
Recruitment to the parent’s focus group was unsuccessful as the parents approached were unable 
to commit to being involved or were reluctant to be involved mostly voicing concerns about 
offering any criticism about the quality of care their children had received. Therefore, no results 
were obtained 
73 
 
 
 
However, after the study commenced, the mother of one of the children who had attended 
rheumatology at RHSC was interviewed by Arthritis Today magazine, the quarterly magazine 
produced by Arthritis Research UK, and the comments she made were considered relevant and 
important in the absence of the focus group data.  This parent had not had a good experience and 
complained about a delay to diagnosis saying that her son had experienced symptoms for 
approximately four years prior to diagnosis. She had an excellent relationship with her 
community paediatrician but felt she wasn’t taken seriously while trying to find out a reason for 
her son’s symptoms and commented ‘if we hadn’t been his parents, pushing all the time, he 
wouldn’t be diagnosed yet’. She expressed frustration due to the implication that she had to 
expect issues with her son’s health due to his DS. ‘The older doctors in particular took the view 
that we had to lower our expectations for him because he had Down’s syndrome’. This parent 
has been quite happy with her son’s treatment since diagnosis but wishes he had been diagnosed 
earlier as he has significant joint damage.  
 
4.5  Paediatric rheumatology specialists 
 
The paediatric rheumatology specialist’s focus group was asked about delay to diagnosis, 
response to treatment and education requirements. This group comprised of three consultant 
paediatric rheumatologists and a paediatric rheumatology specialist nurse.  
 
4.5.1 Inclusion criteria 
 
Paediatric rheumatologists working within RHSC, Glasgow 
Paediatric rheumatology nurse specialists working within RHSC, Glasgow 
 
4.5.2  Exclusion criteria 
 
Paediatric rheumatology clinicians not directly managing inflammatory arthritis in children, 
including children with DS 
 
4.5.3 Questions 
 
Q1. How often have you seen children with Down’s syndrome attend with arthritis? 
 
Q2. Were you aware there may be a link between DS and arthrtitis? 
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Q3. What have your experiences been with regard to symptom onset to referral time and 
involvement of other specialties?   
 
Q4. Do you think there is any specific education needed within rheumatology for arthritis in DS? 
 
4.5.4 Results 
 
The main themes extracted from the transcription of this focus group were that these children 
present with severe disease, they do respond to treatment contrary to literature and that education 
is recommended for health professionals to improve identification of MSK disorders in children 
with DS 
 
With regard to the theme of first presentation all the paediatric rheumatologists commented that 
a large number of the children with DS they had seen over the years with arthritis had been seen 
quite late in the process. These are a number of the comments made: ‘I think we do see a lot of 
them late because they have other joint problems and are often hypermobile and if their mobility 
drops people assume it’s due to their DS or hypermobility’. ‘One had been told by a series of 
health professionals that her mobility was deteriorated due to her associated cardiac disease 
which had been stable so why her mobility should be getting worse I don’t know’. ‘Similar 
experience. Cases seen presented late for the same sort of reasons – symptoms not put down to 
arthritis’. The consensus of opinion was that these children present late with those presenting 
early in the disease process being a small minority. This concurs with the findings of previous 
literature that this group of children present late ( Yancey et al, 1984; Olson et al, 1990; Juj et al, 
2009). 
 
Previous literature has suggested that these children do not respond well to treatment (Yancey et 
al, 1984; Olson et al, 1990) but all the rheumatologists agreed that the response to treatment was 
good despite this suggestion. ‘Ones I’ve seen tend to respond to quite a low dose of methotrexate 
and joint injections as standard JIA’. ‘First went to a hospital there were a number of children 
with DS around the clinic and there was undoubtedly a feeling that you shouldn’t use 
methotrexate and they didn’t respond to treatment therefore you didn’t treat them and I had quite 
a battle to get 3 of them on methotrexate – about 1995’. ‘Methotrexate had been around for a 
number of years (about 7) and people were using in other JIAs but I think there was still this 
thing about DS arthritis was different and they won’t respond to treatment and therefore you 
don’t give them this nasty drug but once we’d treated a few and clearly they had responded 
people shifted their thinking’. ‘When I started in paediatric rheumatology they were considered 
different and they weren’t given methotrexate because they didn’t respond but we now know 
they do respond’. Again the consensus was that these children respond well to modern 
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treatments for JIA and should be treated accordingly concurring with the RHSC pilot study 
(Cruickshank et al, 2008) and the case studies described by Juj et al (2009). 
 
Following on from the discussion about delay to diagnosis there was also a consensus that other 
healthcare professionals would benefit from education on musculoskeletal problems in DS, 
particularly arthritis as it does not appear to be getting recognised at other health care 
appointments, possibly because these children present in an atypical manner. ‘One seen by 
multiple people and was under orthopaedics because of her hypermobility and unstable ankles 
and had repeatedly been pointed out by physios that she had joint swelling and it was just said 
that it was because she’s got very flexible joints’. ‘Interesting that people have actually 
documented in the notes swollen joints, synovitis and somehow the penny hasn’t dropped’. ‘It’s 
in a different box from DS in people’s heads. Or that pain and stiffness are what you expect in 
arthritis and you don’t get that history even though you’ve got all the rest of it’  
 
The main conclusions drawn from the themes obtained from this group were that this population 
of children tend to present late to rheumatology and, therefore, education of health professionals 
who review these children regularly would be beneficial but, once seen, these children do 
respond well to treatment. 
 
4.6  Community paediatricians 
 
The community paediatricians’ focus group was asked about their awareness of musculoskeletal 
problems in children with DS and any training needs they thought might be useful.  
 
4.6.1 Inclusion criteria 
 
Community paediatricians based in Glasgow performing annual reviews in children with DS. 
 
4.6.2 Exclusion criteria 
 
Community paediatricians not performing annual reviews in children with DS. 
 
4.6.3 Questions 
 
Q1. Do you all have much involvement with children with Down’s syndrome? 
 
Q2. What are the main focuses of your annual review of these children? (Or regular review if non 
Drs present?) 
76 
 
 
What kind of physical examination would it involve? 
 
Q3. Do you think these children are prone to musculoskeletal problems? ------ what MSK 
conditions would you consider to be a problem in these children? 
 
Q4. We are looking to evaluate and improve the recognition and diagnosis of arthritis and other 
musculoskeletal problems in these children – can you make any suggestions how we can go about 
this and can you recognise any training needs? 
 
4.6.4 Results 
 
Unfortunately the recording equipment failed during this focus group so only the minuted 
version was transcribed. 
 
The main themes from this focus group were that this group of health professionals were not 
aware of certain MSK disorders in children with DS, they considered MSK problems to be an 
acute issue they would not discover and MSK examination is not part of the annual review 
process.  
 
When asked about MSK disorders in these children a number commented that they examine the 
children for atlanto-axial instability and hip instability but none suggested arthritis as a possible 
condition. One commented ‘I didn’t realise arthritis was a problem in DS’ 
 
When asked if the annual review could be useful in recognising arthritis and other MSK 
problems in this population the general consensus was that any musculoskeletal problems would 
be picked up by another healthcare professional outwith the annual review process. ‘Joint 
problems would be picked up by the GP or school physiotherapists between annual review 
appointments’ 
 
This theme continued with the discussion on education as the general impression was that they 
did not consider education was an important issue at present as they wouldn’t have to deal with 
these conditions at the annual review. It was considered that arthritis would present as an acute 
condition and the parents would attend their GP with any concerns.  
 
Time constraints also appeared to be an issue with the annual review appointment and one 
paediatrician suggested that we could share data collected from the study visits for their annual 
review visit which would save them time.  
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4.7 Discussion 
 
 The main themes from the focus groups were that children with DS do appear to be referred late 
to rheumatology despite numerous healthcare contacts, these children do respond to current 
treatments in contrast to the literature, that community paediatricians consider arthritis to be an 
acute presentation of pain or joint swelling that they would not have to diagnose and that 
education is required to increase awareness and improve diagnosis and prognosis. 
 
The paediatric rheumatologists had all seen children who had been referred late which meant 
that joint damage was worse due to prolonged inflammation before appropriate referral. Some of 
these children had been seen by numerous departments including community paediatrics, school 
nurses, physiotherapists, general practitioner and orthopaedics. One had been told that her 
mobility problems were due to her cardiac condition and another was told that her joint swelling 
were due to her very flexible joints. Arthritis hadn’t been considered as a diagnosis.  
 
There also seemed to be an expectation that these children should have lower levels of mobility 
because of their DS. These children do tend to be hypermobile with podiatric conditions such as 
pes plano valgus but this should not necessarily have an impact on their mobility. 
 
The parent interviewed by Arthritis Today complained about a delay to diagnosis despite a 
number of healthcare appointments. However as other parents were unable to participate in a 
focus group this does not give an all round view of parents experiences and the pilot study does 
identify three children who were seen by a General Practitioner or Accident and Emergency and 
referred promptly to rheumatology.  
 
Previous literature has described children who did not appear to respond to treatment (Yancey et 
al, 1984; Olson et al, 1990) but the paediatric rheumatologists experience was that these children 
were treatment responsive concurring with the more recent case studies presented by Juj et al 
(2009). Early diagnosis is vital to allow treatment to commence before any joint damage has 
occurred. Unfortunately for a lot of these children their joints are badly damaged before they are 
referred to rheumatology. One rheumatologist said of a former patient who was referred after a 
long period of time ‘He’s sad because he’s completely wrecked all his joints and actually he’s 
very treatment responsive’.  
 
The community paediatricians appeared to think that arthritis was something that they would not 
have to diagnose as it would present as an acute complaint of pain or joint swelling and would 
be seen by a GP or school nurse. This may not be the case as these children may not display an 
acute presentation. As discussed in Chapter 2, literature suggests that these children do not 
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appear to express pain in the same way as the general population (Lind et al, 1990; Biersdorff et 
al, 1994; Martinez-Cué et al, 1999; Hennequin et al, 2000) and, in her interview with Arthritis 
Today, our parent said that her son never complains of pain but says that his joints are tickly. 
Also, anecdotally, a large number of parents involved in the study commented that their children 
didn’t generally complain of pain. If a child doesn’t complain of pain, their parents may not pick 
up on a warm or slightly swollen joint immediately. These children may develop a change of 
gait or movement or even a change in mood due to pain or discomfort in a joint which the parent 
may not consider to be an acute problem. Most parents would not consider a change of mood to 
be caused by pain or discomfort but may query this at the child’s next annual review with their 
community paediatrician. 
 
The pilot study at RHSC, Glasgow raised concerns over the delayed diagnosis of this population 
of children and the results suggested that there may be issues with diagnosing MSK disorders in 
this population. 
  
These focus groups show that education is vitally important for other health professionals to 
have better awareness of joint problems in this group of children, and their unique presentations, 
to allow earlier and better diagnosis. As the paediatric rheumatology specialists discussed, 
children had seen multiple healthcare professionals and still had been misdiagnosed but the 
community paediatricians felt education wasn’t an important issue as they thought what they 
considered to be an acute problem would be dealt with by another health professional. However 
if a parent comes to annual review and mentions a change of gait or mood, the community 
paediatrician needs to be aware that arthritis should be considered. School nurses, 
physiotherapists and other healthcare professionals who attend to these children regularly should 
be included in education so they would be able to pick up a possible arthritis when seeing the 
child. One child mentioned by the paediatric rheumatologists had been seen by multiple people 
and was only referred because an occupational therapist was asked to give a school hand 
assessment and phoned the GP to ask for a rheumatology referral. An issue with this child’s 
hand had been identified but not recognised as arthritis. Education of these health professionals 
would also help improve expectations of these children and allow understanding that their 
mobility shouldn’t be any different from the general population. Education of parents would also 
improve their awareness of signs and symptoms and allow them to be confident about querying 
symptoms with their GP or community paediatrician. 
 
Since holding the focus group with the community paediatricians, awareness in musculoskeletal 
conditions has improved and a number of referrals have been received at RHSC Yorkhill 
following annual review consultations. Also a number of community paediatricians have 
attended an annual study day  run by one of the consultant rheumatologists at RHSC Yorkhill on 
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paediatric musculoskeletal conditions (although not specifically in DS) which includes 
recognition of symptoms, diagnosis, examination and treatment. Other specialties are involved 
including podiatry, occupational therapy and orthopaedics. 
 
It is hoped that in conjunction with Arthritis Research UK educational material for health 
professionals and parents can be produced to raise awareness of symptoms to look out for. It 
would also be beneficial if a musculoskeletal examination could be included in the annual 
review of children with DS. As discussed in Chapter 2 the short pGALS examination with some 
minor adaptations could be added to a general appointment with minor time disruption. This 
would, hopefully, lead to earlier diagnosis and referral, earlier treatment initiation, faster 
remission and less joint destruction to allow these children to get back to normal mobility across 
a range of MSK disorders including arthritis. 
 
4.8 Limitations and clinical implications 
 
The main limitation of these focus groups was the inability to recruit a parent group to 
understand parent experiences of their healthcare pathway and diagnosis.  
 
With regard to the community paediatricians’ group a major limitation was the lack of a 
recording as the equipment failed and an administrator’s transcript was all that was available. 
Also this was a large group as it was part of an educational meeting and not all the participants 
entered into the discussion and we may have had a better in depth discussion with more concise 
themes from a smaller group. 
 
The facilitator was new to focus groups and it may have been more beneficial to have a 
facilitator who was experienced with focus groups or a co-facilitator to lead the groups to obtain 
better discussion and a more robust data analysis from the groups.  
 
If the study had had a longer time frame we would have liked to have added focus groups 
involving other health professionals involved in the care of these children such as 
physiotherapists and occupational therapists regarding their experience and knowledge of MSK 
disorders in this population as they may be just as likely to discover a problem in these children. 
This may also have given more robust data from the groups.  
 
From the results obtained, the clinical implications for the future are that, although the 
community paediatricians were reluctant about including MSK examination and felt that MSK 
disorders were something a GP or other health professional would diagnose, awareness has now 
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been raised regarding MSK problems in this population which is hopeful for referral in these 
children in the future. 
 
Also, the pilot study at RHSC, Glasgow (Cruickshank et al, 2008) and the case studies presented 
by Juj et al (2009) showed that these children respond to treatment in comparison to previous 
literature and the comments from the rheumatology specialists back this up, so children 
diagnosed with arthritis in future can be prescribed rheumatology medication early allowing 
better prognosis. 
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CHAPTER 5 
 
HYPERMOBILITY   
 
5.1 Introduction 
 
Joint hypermobility (JH) describes lax ligaments around the joint allowing the joint a wider range 
of movement (ROM) than is considered normal in an asymptomatic individual. Joint hypermobility 
syndrome (JHS) describes this condition but involves symptoms which can include joint pain, foot 
pain and joint dislocation. ‘Hypermobility may pose no problems, but in some individuals it 
predisposes to a wide variety of soft tissue injuries and internal joint derangements, arthritis, 
arthralgias or myalgias, which lead sufferers to seek medical attention (Simmonds and Keer, 2007). 
 
The majority of literature describing Down’s syndrome mentioned hypermobility, lax ligaments 
and muscle hypotonia present in these individuals which can cause mobility and instability 
problems. Despite this, literature that examined generalised hypermobility in children with DS is 
very limited. The majority of the literature examining JH within the DS population looked at 
hypermobility in relation to joint instability, particularly instability of the atlantoaxial joint. Clinch 
et al (2011) examined hypermobility within the general population of fourteen year old children but 
acknowledged that JH can be present within other genetic disorders and syndromes such as 
osteogenesis imperfect, Marfan syndrome, trisomy 21 and bony dysplasia.  
 
JH is recorded by using the Beighton scoring system (Beighton and Horan, 1969) (Table 3.3) and 
JHS diagnosed using the 1998 revised Brighton  criteria (Grahame, Bird and Child, 2000) (Table 
3.4). Beighton score gives a whole number score ranging from zero to nine. A Beighton score of 
over four is considered to be a sign to identify hypermobility and counts as a major criteria in the 
Brighton scoring system. The Brighton scoring system uses 2 major criteria and 8 minor criteria 
with a diagnosis of JHS depending on a certain amount of these scores being fulfilled (Table 3.4). 
‘The BJHS is diagnosed in the presence two major criteria, or one major and two minor criteria, or 
four minor criteria. Two minor criteria will suffice where there is an unequivocally affected first-
degree relative’(http://hypermobility.org/hypermobility/do-i-have-hms/the-brighton-score/). 
 
Hypotonia is described in DS particularly in newborns and may be a factor in delayed motor 
response in these children. Infants with DS are floppy at birth and start walking later than the 
general population. They display a gait with shorter steps and a longer stance time and delayed 
developmental motor responses compared to children without DS (Shumway-Cook and 
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Woollacott, 1985; Selby-Silverstein et al, 2001; Gontijo et al, 2008; Chang et al, 2009, Rigoldi et 
al, 2011).  
 
5.2 Methods 
 
73 children (28 boys; 45 girls) aged between 2.4 and 15.9 (median 8.94) were recruited from an 
identified population of 142 children with DS resident in Glasgow and examined as described in 
Chapter 3.  
 
A complete musculoskeletal examination based on the pREMS procedure (Appendix 3: Foster et 
al, 2011) and a podiatric examination by a senior podiatrist were carried out.  
Joints were examined and recorded as hypermobile if an MCP, MTP, wrist, ankle, hip or shoulder 
joint fulfilled the criteria of hyperextending over 90 degrees or an elbow or knee joint fulfilled the 
criteria of hyperextending more than 10 degrees. The Beighton and Brighton scoring systems were 
used as part of the examination. Parents were asked to complete questionnaires about their child’s 
past medical history, family history and to identify any musculoskeletal concerns. 
 
In order to make some comparison with the degree of hypermobility in the normal paediatric 
population  some comparisons were made with the numbers by Clinch et al (2011) who analysed a 
cross section of the population based cohort from the ALSPAC study (www.alspac.bris.ac.uk). 
6032 14 year old children attended the research centre and hypermobility data was collected using 
the Beighton scale. This study was used as a comparison as they were closest in the literature 
although this was a poor match as the Clinch et al cohort were all 14 years old and the DS study 
cohort ages ranged from 2 to 15. 
 
As there is no way of measuring hypotonia a revised version of the CMAS score (Lovell et al, 
1999) was used to assess weakness. A number of the measurements included in the CMAS score 
involved a measurement of duration. It was decided prior to the study commencing that these 
measurements would be removed from the scoring due to the level of learning disability of these 
children and their ability to comply with the study measurements. 
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5.3 Results 
 
73 children (28 boys; 45 girls) aged between 2.4 and 15.9 (median 8.94) were recruited from this 
cohort and examined according to the study protocol Appendix 1). 51 children did not respond to 
the invitation, 18 declined, cancelled or did not attend appointments and these 69 children (35 
boys; 24 girls) not seen were aged between 2.2 and 15.9 (median 9.77). Deprivation category by 
postcode was not documented in the study. 
 
5.3.1 Joint examination 
 
71 (97%) children demonstrated hypermobility from the criteria in at least one joint. Hip joints 
were the most commonly hypermobile with 56 (77%) children demonstrating at least one 
hypermobile hip joint and 111 hip joints out of the 146 examined demonstrating hypermobility.  
Figure 5.1 and Tables 5.1 to 5.3 below show the breakdown of joints which fulfilled criteria for 
hypermobility. The majority of hypermobile joints in this cohort of children were in the lower 
limbs. 
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Figure 5.1: The distribution of hypermobile joints in 73 study children: MTPs;        
metatarsophalangeal joints: TN; talonavicular: ST;subtalar: MCPs; metacarpophalangeal 
joints 
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Table 5.1: The distribution of hypermobility in lower limbs of this DS study cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lower limbs Joints Number/73 (%)  
Hips 111/146    
(76%)  
56    (77%)  
Knees  47/146    
(32%)  
24    (33%)  
Ankles 80/146    
(55%)  
41     (56%)  
Subtalar  82/146     
(56%)  
41     (56%) 
Talonavicular  88/146     
(60%)  
44    (60%) 
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Upper limbs  Joints  Children/73 (%)  
Shoulders 32/146    (22%)  16    (22%)  
Elbows 16/146    (11%)  8    (11%)  
Wrists 20/146    (14%)  10     (14%)  
 
 
Table 5.2: The distribution of hypermobility in upper limbs of this DS study cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Small joints Joints (730) No. of children (%) 
MTPS  459         (63%)  46 (63%)  
MCPS  239         (33%)  20 All MCPS (27%)  
44 MCP5 (60%)  
PIPS  30            (4%)  3 (4%)  
Neck  1 (1.4%) 1 (1.4%) 
 
 
Table 5.3: The distribution of hypermobility in small joints and the neck joint in this DS study 
cohort: MTPs; metatarsophalangeal joints: MCPs; metacarpophalangeal joints: PIPs; proximal 
interphalangeal joints (20 (27%) children showed hypermobility in all MCPs and 44 (60%) 
children showed hypermobility in their MCP5 joint which is one of the joints checked on the 
Beighton scoring system) 
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5.3.2 Beighton scores 
 
The breakdown of Beighton joint scores from the study cohort showed a prevalence of generalised 
joint laxity in 39 (53%) of the children as defined using a Beighton score over or equal to 4.   
 
The cohort from this study showed higher numbers of children with Beighton scores >4 and >6 
(Table 5.5) as compared with Clinch et al scores and a comparison of 13-16 year olds in this study 
also showed this age group displayed higher levels of hypermobility (Table 5.7). Clinch et al’s 
cohort showed hypermobility to be more prevalent in girls. The DS study cohort showed similar 
levels of hypermobility between the two sexes (Table 5.6).  
Comparison was made between the distribution of joints in the DS study cohort and the Beighton 
scale. Only 1 joint was found to correspond in both - the fifth metacarpal joint (Figure 5.2) 
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Table 5.4: The distribution of Beighton scores in the study cohort of DS children (n=73) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beighton Score 
 
Number of 
children 
1  16  
2  10  
3  8  
4  16  
5  5  
6  8  
7  9  
8  0  
9  1  
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Table 5.5: The comparison of Beighton scores from the DS study cohort  with Beighton scores from 
Clinch et al (2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beighton 
Score 
(0-9) 
DS study 
results 
population 
prevalence 
n/73 (%) 
Clinch et al 
population 
prevalence 
n/6022 as a 
percentage 
DS study 13-16 
year olds 
prevalence n/21 
(%) 
>4 39  (53%) 19.2% 10 (48%) 
>6 18  (25%) 4.2% 3 (14%) 
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Table 5.6: The comparison of Beighton scores between the sexes in Beighton scores ≤4 and  ≤6 in 
the DS study cohort and Clinch et al (2011) cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Children Our results 
Beighton >4 
 
Clinch et al 
Beighton >4 
Our results 
Beighton  >6 
Clinch et al 
Beighton  >6 
Boys 57%  10.6% 25%  1.3%  
Girls 51%  27.5% 24%  7%  
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Table 5.7: Table showing Beighton scores for 13-16 year olds within the DS study cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beighton Score Number of Children 
/ 21 
% 
0 6 29% 
2 2 9% 
3 3 14% 
4 6 29% 
5 1 5% 
6 2 9% 
7 1 5% 
93 
 
 
 
 
 
 
 
 
 
 
 
 
                      
 
 
 
            
            
          
 
 
 
 
 
 
Figure 4.2 
The joints examined in the Beighton     The joints found to be 
hypermobile 
hypermobility scoring criteria showing    within the DS study cohort 
showing 
carpo-metacarpal joints; 5th metacarpal    5th metacarpal joint;, hip;, 
subtalar  
joints; elbows; knees and lower back    joints; talonavicular joints and all 
        metatarsal joints 
 
 
 
 
 
Figure 5.2 
 
 
The joints examined in the Beighton    The joints found to be hypermobile 
hypermobility scoring criteria showing   within the DS study cohort showing 
carpo-metacarpal joints; 5th metacarpal   5th metacarpal joint, hip, subtalar  
joints; elbows; knees and lower back   joints, talonavicular joints and all 
       metatarsal joints 
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5.3.3 Brighton scores 
 
The DS cohort of children displayed high levels of individual joint hypermobility but Brighton 
scores were low in this cohort with only 11 (15%) children fulfilling the criteria for a diagnosis of 
JHS.  
 
5.3.4 Hypotonia 
The children generally scored highly using the revised CMAS scoring system for the study. (Table 
5.9) 
 
5.3.5 Anecdotal results 
 
A number of parents whose children participated in the study, and no other pathology was found, 
commented that their children would stop suddenly while walking and refuse to walk any further. 
Some of them would sit down where they stopped and a number of mothers travelled with a buggy 
for older children. This may be related to discomfort due to hypermobility in the lower limbs. 
Another common comment within the parents of the study cohort was that the children were most 
comfortable with their legs in the lotus position or wrapped around their neck as illustrated by one 
of the boys in the study cohort in Picture 5.1. One parent even commented that their child regularly 
ate in that position causing some comment when eating out. 
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Table 5.8 The distribution of Brighton major  
score criteria in this DS study cohort                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.9 The distribution of Brighton minor criteria in this DS study cohort 
 
 
 
 
 
 
 
 
 
 
 
Brighton Major 
Score  
Number of 
Children  
0  33  
1  40  
Brighton Minor 
Score  
Number of 
Children  
0  0 
1  45  
2  20  
3  6  
4 2 
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CMAS scores Number of Children 
/ 73 
% 
18 1 1% 
20 1 1% 
23 1 1% 
24 5 7% 
25 4 5.5% 
26 6 8% 
27 4 5.5% 
28 7 10% 
29 6 8% 
30 10 14% 
31 9 12% 
32 12 16% 
Non Compliant 7 10% 
 
Table 5.10: Table showing distribution of CMAS scores within the study cohort 
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5.4 Discussion 
 
A high level of hypermobility was expected in this cohort of children in accordance with DS 
literature and our study showed 97% of children fulfilling criteria for hypermobility in at least one 
joint. However the pattern of hypermobility found in DS does not correlate with the Beighton and 
Brighton scoring systems.  
 
Although the Beighton scores showed 53% of the study cohort appeared to be hypermobile, the 
Beighton scoring system uses 9 specific joints and the results from study joint exam discovered that 
the pattern of hypermobile joints in the study cohort were mainly in the lower limbs and did not 
correlate with the joints examined within the Beighton scoring system as illustrated in Figure 3.2. 
The only joint that occurred in both the Beighton scale and was frequently hypermobile in DS was 
the fifth metacarpal phalangeal joint .  This suggests that the Beighton and Brighton scores 
underestimate the level of hypermobility in DS and that a disease specific score is needed. 
 
The Beighton scoring system was not developed as a diagnostic test (www.hypermobility.org) due 
to its limited sample of joints but the joint pattern found within this cohort of children suggests that 
the Beighton scoring system is not useful in this population and a complete joint examination 
focusing particularly on the lower limbs would be more useful in determining level of 
hypermobility. Because the majority of hypermobile joints are lower limb joints this then impacts 
on mobility levels and weightbearing for this population, particularly with other compounding risk 
factors such as obesity. 
 
The comparison between the DS study cohort and Clinch et al’s (2011) cohort showed a higher 
percentage of children fulfilling the criteria for hypermobile joints in the DS cohort which would 
suggest higher levels of hypermobility in this population of children and a direct comparison of 13-
16 year olds showed higher levels of hypermobility in this study cohort. However the age range of 
the DS cohort between two and sixteen was considerably different with Clinch et al’s cohort all 
aged 14 and the DS cohort population of aged 13 -16 was only 21 and therefore is not a large 
enough representative number to draw an accurate comparison . This suggests the difference in 
hypermobility could be due to different ages and would be a more accurate representation  if the 
DS study cohort had been all of a similar age to the Clinch et al cohort. 
 
The hypermobility levels were high in the DS cohort of children but the Brighton scores did not 
suggest a high level of joint hypermobility syndrome. The Brighton scoring system uses the 
Beighton scale and takes other clinical factors into account for diagnosis. (Figure 3.3) 
 
One of the minor Brighton criteria is the ‘anti-mongoloid’ slant of the eyes which is present in all 
children with Down’s syndrome and, therefore, gave all the children in the study cohort one minor 
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score automatically. Another minor Brighton score is complaining of pain in one or more joints for 
3 months or longer. Literature suggests that this population of children appear to display reduced 
perception of pain as discussed in Chapter 2. A reduced perception of pain would make this minor 
score difficult to judge. A large number of parents commented anecdotally that their child did not 
complain of pain, particularly in comparison to their siblings.  
 
There is also debate within literature about the level of Beighton score that should be applied to the 
Brighton criteria. The current major criteria is a Beighton score of four or more out of nine but 
Smits-Engelsman, Klerks and Kirby (2011) recommended a score of seven out of nine after 
concluding that their threshold of five out of nine classified children as hypermobile incorrectly. 
The limitations to the Brighton scoring system suggest that it may not necessarily be suitable as a 
diagnosis tool for this population of children. 
 
The CMAS scores obtained were generally high and the exercises carried out well by the children. 
The lower scores obtained were mainly by children who were not completely compliant with the 
exercises. The most useful exercises for measuring weakness within the CMAS were the sustaining 
exercises but these were not used as it was considered these children would not have the 
concentration to sustain the exercise. This suggests that this scoring system is not useful in this 
population, and was a poor proxy for hypotonia. Developing an alternative method of measuring 
hypotonia in children with DS would be of value.  
 
In conclusion, this population of children displays a high level of hypermobility which is 
underestimated using the Beighton and Brighton scores because it affects a different set of joints 
than used in these scoring systems. Introducing a general joint examination with focus on the lower 
limbs to the annual review process of these children would help to understand mobility issues 
caused by hypermobility. It would also screen this population of children for other musculoskeletal 
complaints. We were unable to make objective assessments of hypotonia. 
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Picture 5.1: Picture of study participant showing hypermobile hips 
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CHAPTER 6 
 
MUSCULOSKELETAL  RESULTS 
 
6.1 Introduction 
 
Published case reports of children with DS presenting with an inflammatory arthritis (Yancey et al, 
1984; Juj et al, 2009, Padmakumar et al, 2002, Olsen et al, 1990) showed that most of these 
children presented late with significant disease and did not appear to respond to the treatments 
given. 
 
A pilot study carried out in The Royal Hospital for Sick Children, Glasgow (Cruickshanks et al, 
2008) identified 12 children who had attended the paediatric rheumatology service in Scotland. A 
number of these children presented late despite numerous contacts with health professionals, 
including annual review by community paediatricians, regular contact with physiotherapists and 
school nurses and appointments with orthopaedic consultants. Figures showed a median age at 
symptom onset of 5.9 (2-13.3) years but a median age at diagnosis of 8.1(4.2-15.6) years. This 
corresponded with the median time from symptom onset to first paediatric rheumatology 
appointment of 2.9 (0.1-8.7) years. This contributed to already established, destructive disease at 
presentation and four of the children were non weight bearing at first appointment. However these 
children responded well to treatments offered. This is in contrast to previous literature which may 
suggest modern treatments are more effective. This pilot study identified five children resident in 
Glasgow with DS and juvenile arthritis in a DS population of 174 identified from three separate 
registers available. This gave a prevalence of 2.87% and a relative risk of 3.38 of developing JIA in 
DS compared to children without DS, assuming a prevalence of JIA in 1 in 1000 children 
(Andersson-Gare, 1999). 
 
An ongoing study being carried out in Ireland performing a screening MSK examination on 
children with DS from birth to 18 years has diagnosed 10 new cases of arthritis (from a population 
of 164 examined to date) compared to 11 already known from a ten-fold larger population of 
children with DS (personal communication O Killeen 2013). In contrast to the RHSC study, 
however, their anecdotal evidence suggests methotrexate intolerance as 24% of their current cohort 
were commenced on methotrexate and all have been discontinued due to lack of tolerance and 
failure to respond so it will be very interesting to compare their final study results with evidence 
from the RHSC pilot study. 
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Studies have also showed that children with DS appear to display higher levels of pain tolerance or 
express pain differently (Lind et al, 1970; Hennequin et al, 2000) which was considered a factor in 
misdiagnoses as joint pain would generally be one of the first signs of inflammatory arthritis.  
 
This late presentation led to the hypothesis that there may be undiagnosed arthritis within the 
community of DS children as the children identified had lived with their arthritis for a median of 3 
years without diagnosis.  
 
6.2 Methods 
 
73 children (28 boys; 45 girls) aged between 2.4 and 15.9 (median 8.94) were recruited from an 
identified population of 142 children with DS resident in Glasgow and examined as described in 
Chapter 3.  
 
All joints were examined for the range of movement, heat, swelling and pain or tenderness and any 
findings documented. All children were offered referral to paediatric rheumatology following the 
study visit whether the study personnel had concerns or not as it was considered that inviting the 
children to take part in the study may have raised concerns or questions with the parents.  
 
A full podiatry examination was carried out by the same consultant podiatrist and is discussed fully 
in Chapter 7. 
 
Schobers test was carried out to determine any limitations in spine movement. 
 
Parents were asked to complete questionnaires involving past medical history, family history and 
any musculoskeletal concerns. Pain threshold was recorded within the study questionnaires as a 
visual analogue scale (VAS) within the CHAQ form where parents were asked to record their 
child’s pain level at its worst over the last seven days on a 100mm line and the pain score is 
recorded as a measurement of  x/100mm. 
 
In this study we undertook anthropometric measurements including height, weight, sitting height, 
arm span and head circumference of the study population of children with Down’s syndrome which 
will allow comparison to previous populations, particularly in a time of worldwide concern about 
increasing levels of obesity, and to consider whether there was a relationships with their MSK 
findings and mobility levels.  Normative values for height and weight were taken for comparison 
with this cohort from two sources.   Height and weight data were compared to the Down’s 
normative LMS data compiled by Styles et al (2002) who collated data from a cohort of 1089 
children and young adults with DS to develop more up to date centile charts for the DS population. 
Measurements of height, weight and head circumference were recorded from health records, 
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cleaned and studied. Centile charts were then fitted to data using the LMS method (Cole et al, 
1998).  Previous studies referred to as the UK90 data collected measurements from birth to 70 
years old was assessed across seven studies in the UK and the results from these led to the 
development of growth centile charts from birth to 20 years old (Freeman et al, 1995). As Styles et 
al failed to report normative values for BMI in the DS population despite measuring height and 
weight we were unable to compare this cohort to the Down’s data and were forced to make the less 
appropriate comparison to the BMI for the normative population from the UK90 data, and only to 
height and weight individually from Styles data. 
 
6.3 Results 
 
73 children (28 boys; 45 girls) aged between 2.4 and 15.9 (median 8.94) were recruited from this 
cohort and examined according to the study protocol Appendix 1). 51 children did not respond to 
the invitation, 18 declined, cancelled or did not attend appointments and these 69 children (35 
boys; 24 girls) not seen were aged between 2.2 and 15.9 (median 9.77). Deprivation category by 
postcode was not documented in the study. 
 
6.3.1 Joint exam 
 
In the 73 children screened none had active synovitis but 22 children (30%) showed joint 
limitations in at least one joint. This limitation may have been only on one movement within the 
joint such as inversion only or eversion only. In four children hip joints showed hypermobility on 
external rotation but appeared limited on internal rotation. Sixteen children (22%) displayed 
limitations in two or more joints. The majority of limited joints were discovered in lower limb 
joints as shown in Table 6.1. Three children were completely non compliant with the joint exam 
and one only allowed upper joints to be examined. Of the three non compliant children, two were 
severely autistic. However, in these children, some results were obtained by observation, 
particularly evidence of hypermobility.  
 
6.3.2 Referral 
 
A total of 28 (38%) children from a total cohort of 73 were referred to the paediatric 
rheumatologist. All referred children had displayed some joint limitation at study visit. 1 child 
failed to attend for appointment. None of the children who attended had any evidence of active 
synovitis on examination by the paediatric rheumatologist. Two children displayed ongoing hip 
limitation with corresponding mobility changes. These children underwent MRI scanning. Neither 
showed joint abnormalities, however, one child was discovered to have an undescended testicle. 
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6.3.3 Pain response 
 
Pain was recorded as a visual analogue scale (VAS) within the CHAQ as a measurement of 
x/100mm. Anecdotally, a large number of parents commented that their children did not complain 
of pain and were more likely to complain of tiredness and just stop walking and sit down. There 
were also a number of comments about how their children didn’t complain of pain when they fell 
or bumped themselves. The VAS scores ranged from 1mm to 47mm with a median of 10.6mm. 
 
6.3.4 Anthropometric results 
 
There was no statistically significant difference for height or weight when compared to the Down’s 
normative data (Styles (2002). There was no statistical difference between the sexes in comparison 
to Styles (2002) (Table 6.2). Comparison with the UK90 data showed that the children with DS 
were shorter and heavier than the general population as would be expected. 
 
Only seven children (10%) were found to be obese (weight > 95th centile) (Table 6.4). Centile value 
was depicted in weight as Styles et al had failed to report normative values for BMI and we were 
unable to compare for normative DS data.  
 
18 (25%) of the children were non-compliant with standing on the Tanita scales for BIA and scores 
ranged from 383 to 797 (median 566). However this data was not used for analysis as there were no 
comparable studies to compare results with for this population. 
 
6.3.5  CHAQ form results 
 
58 CHAQ questionnaires were returned following the study visits. CHAQ forms are scored from 0 
(no disability) to 3 (severe disability). CHAQ forms are scored form 0 (no disability) to 3 (severe 
disability) (Groen et al, 2010). Study CHAQ scores ranged from 0 to 2.5 with a mean of 1.39 and a 
median of 1.56. 18 questionnaires scored under one (31%), 25 (43%) scored between one and two 
and 15 (26%) scored over 2.  
 
6.3.6 Schober’s test results 
 
18 (23%) of the children were non compliant with the Schober’s test, 21 (30%) had a result above 
15 but below 21 and 34 (47%) had a result above 21 
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Table 6.1: Table showing limited joints found on examination, expressed as joint number and by 
child. ST; subtalar: TN; talonavicular: MCP; metacarpophalangeal joints: PIP; proximal 
interphalangeal joints: MTP; metatarsophalangeal joints 
 
 
 
 
 
 
 
 
 
 
 
 
Joints Limited joints Total children 
Ankles 19   (13%)  10   (14%)  
Hips 11  (8%)  6   (8%)  
Knees  9  (6%)  6   (8%)  
ST  4   (3%)  3  
TN  0  0  
Shoulders  2  1  
Elbows 1  1  
Wrists 1  1  
MCP  1  1  
PIP  1  1  
MTP  0  0  
Neck  3   (4%)  3  
Enthesitis 0  0  
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Variable N Mean StDev SE Mean    95% CI T P 
Height  70 -0.155     1.119 0.134 (-0.422,  0.111) -1.16 0.249 
Weight  70 -0.012     1.267 0.151 (-0.314,   0.291) -0.08 0.939 
Head 
circumference  
67 0.645     1.221 0.149 ( 0.347,    0.943) 4.33 <0.001 
 
 
Table 6.2: Table showing the mean group comparisons between study cohort data for height, 
weight and head circumference against the Down’s normative data given as standard deviation 
scores (Styles et al, 2002) 
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Variable N Mean StDev SE Mean    95% CI T P 
Height  70 -2.340 1.236 0.148 (-2.635,  -2.045) -15.83 <0.001 
Weight  70 -0.485     1.598 0.191 (-0.866,   0.104) -2.54 0.013 
Head 
circumference  
70 1.117     1.322 0.158 ( 0.802,    1.432) 7.07 <0.001 
 
Table 6.3: Table showing the mean group comparisons between study cohort data for height, 
weight and head circumference against the UK90 data given as standard deviation scores 
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Weight Number of children 
n= 73 
% 
Obese ( weight >95th 
centile) 
7 10 
Overweight ( weight 
>85th-95th centile) 
7 10 
Underweight 
(weight <2nd centile) 
3 4 
 
Table 6.4: Table showing number of children with weight results outside normal values 
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6.4 Discussion 
 
No new arthritis cases were discovered by the study and this means the ten year prevalence from 
2008 of 2.87% is unchanged. However the study cohort represented 51% of the DS population and 
future studies would be advisable to try and capture a higher percentage of the population although 
one theory for non response to contact for the study was that these parents already have a number 
of hospital appointments and they may not have appreciated another one. This is why it is so 
important that the health professionals that see these children on a regular basis are educated to 
examine for and detect musculoskeletal abnormalities in this population of children. 
 
Approximately a third of these children showed joint limitations on examination but no signs of 
active inflammatory arthritis. The mechanism for the limitation is unclear but possible explanations 
may be compliance, pain or responses to hypermobility. One child had appeared to show neck 
limitation on extension at the study visit but gave full extension when reviewed by a paediatric 
rheumatologist. 
  
Another possibility is that limitation was considered because the joints in these children are 
expected to be hypermobile. At the beginning of the study, the study staff thought these children 
were showing limitations in elbows as they were not giving a positive Beighton score but very 
quickly came to the conclusion that this was the normal range of movement in these children. Only 
8 children in the study displayed hypermobile elbows.  
 
All the children in the study were offered referral to paediatric rheumatology as it was considered 
that the study visit may have raised anxieties within some parents and they may prefer to see a 
rheumatologist to address those anxieties. The majority of parents were very enthusiastic about the 
study and happy to take the advice of the study team but only a small number were keen to take up 
the offer of a referral. All children who had displayed joint limitation were referred to paediatric 
rheumatology for follow up and parents encouraged to attend the appointment. No children were 
found to have evidence of arthritis. However the discovery of an undescended testicle in one of the 
children was an important medical finding for a 14 year old boy.  
 
The anecdotal evidence from the parents that these children do not complain of pain and the VAS 
scores support the RHSC Yorkhill pilot study theory that children with DS have a higher pain 
threshold. One of the study participants was resident in a care facility and had been displaying a 
limp and adjusted walking patterns for a number of months but, while the staff thought this child 
had injured himself when this presented, after several weeks with no complaints of pain they 
considered him to be attention seeking. They did not appreciate that for a child, particularly one 
with learning difficulties, it would not be possible to continue to display the same pattern for a 
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lengthy period of time. A child would change walking patterns and possibly which leg the limp was 
presenting if no discomfort or pain was present. It would be advantageous in a future study to add 
specific questions about pain levels to study questionnaires to examine this. The VAS scores 
themselves may not be relevant as none of the children were discovered to have arthritis and the 
score is therefore a general score by the parents and more relevant questions would be beneficial to 
exploring this topic. 
 
Our main consideration regarding the anthropometric measurements was whether this population of 
children was overweight which would further compound any MSK issues and put added pressure 
on the lower limb joints which have already proven to be considerably hypermobile as discussed in 
Chapter 5. Obesity in children with DS places more strain on the MSK system which makes 
screening for MSK disorders in this population imperative to prevent injury (Murray and Ryan-
Krause, 2010). We anticipated that the study cohort would prove to have an overrepresentation of  
obese patients compared to the Down’s cohort of a decade ago given current health trends, but 
results show that they are not. Although the DS population is described as being shorter and 
heavier than the general population (Cronk et al, 1988; Pueschel, 1995; Cremers et al, 1996; Bosch 
2003; Roizen, 2003; Murray and Ryan-Krause, 2010; Myrelid et al, 2011), and this is shown in the 
comparison between this DS study data and the UK90 data, only seven children in the study were 
shown to be obese and the comparison between this study data and the Down’s normative data 
(Styles et al, 2002) showed no significant difference compared with this cohort reported a decade 
earlier. They do not calculate body mass index (BMI) for this cohort of DS so we had to compare 
height and weight only. This suggests that this study cohort does not appear to show any increase 
in obesity levels within the DS population over the last 10 years but does still appear to show that 
DS children are shorter with higher BMIs than the general population.  
 
Pubertal status was not documented in the study population but may have been a useful 
consideration with regards to growth and development especially as 37 (51%) of the study cohort 
was over the age of 10.   
 
CHAQ forms are based on limitations due to musculoskeletal problems and CHQ forms are based 
on well being in children with underlying disease and were therefore considered to be irrelevant to 
the study results as it was unclear if they had been completed from a musculoskeletal or Down’s 
syndrome point of view. Results from CHAQ forms were unclear regarding any musculoskeletal 
issues as 26% of the forms returned suggested moderate disability and showed the limitations of 
using this form for a population study in this cohort. It was decided not to analyse the CHQ data 
following this conclusion as there was no further funding available to cover the cost of the analysis. 
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Schober’s test in this study cohort was inconclusive as it was unclear if lower values were due to 
lack of understanding of the test and non compliance rather than any spinal limitation. 
 
This population of children is seen regularly by health professionals including community 
paediatricians, physiotherapists and school nurses. Despite this, the pilot study showed that 
musculoskeletal disorders were not being picked up and part of this study was to help raise 
awareness of musculoskeletal disorders in health professionals for children with DS. One intention 
from the study is to educate these health professionals in musculoskeletal examination with an aim 
to developing an education leaflet.  
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CHAPTER 7 
 
 
PODIATRY   
 
 
7.1 Introduction 
 
Specific foot problems are described in DS such as pes planus, syndactyly and hallux valgus which 
can be overlooked in children with DS as more severe problems are frequently (Concolino et al, 
2006).  
 
A number of studies have examined foot pathologies, footwear, gait development and pattern and 
posture (Shumway-Cook et al, 1985; Prasher et al, 1995; Concolino etal, 2006; Selby-Silverstein et 
al, 2001; Galli et al. 2008; Chang et al. 2009; Rigoldi et al, 2010). 
 
Examining for podiatric conditions such as pes plano valgus and deformities such as leg length 
discrepancy is important because early intervention can be made to prevent pain and discomfort 
developing from hypermobility and hypotonia, and limit long term deformity. This intervention can 
be in the use of orthoses such as implants for inside footwear or specially made footwear to support 
the foot and ankle joint and encourage a more ‘normal’ foot posture.  
 
7.2 Methods 
 
73 children (28 boys; 45 girls) aged between 2.4 and 15.9 (median 8.94) were recruited from an 
identified population of 142 children with DS resident in Glasgow and examined as described in 
Chapter 3.  
 
66 of the 73 children were examined by a consultant podiatrist for foot size to shoe size ratio, 
adequacy of footwear, use of orthoses, range of movement, foot type, foot posture in relaxed and 
dynamic phase of gait, lower limb posture, leg length discrepancy, intrinsic foot biomechanics, 
enthesitis, digital and metatarsal formula, digital deformity, skin type and pathologies and nail 
features and pathologies. All these examinations were devised and carried out by a consultant 
podiatrist following current standards and techniques (Goel and Watt, 2010).  
 
66 children of the study cohort were examined by the podiatrist as, due to his retirement, he was 
unable to examine the final 7 children of the cohort and they had MSK assessment only. 
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7.3 Podiatry examination 
 
Shoe size to foot size ratio was examined to assess whether the children were wearing the correct 
size of footwear. This difference was expressed in number of feet rather than children as 16 of the 
children had feet of different sizes and the results compared with the recognised foot health and 
industry standard two size difference (Walther et al, 2008) as it allows for elongation and growth 
within the shoe during gait and prevents the restriction of the feet and toes which could cause 
trauma and deformity (Figure 7.1). 
 
Foot type was assessed as different foot types can have implications for shoe fitting and therefore 
trauma and deformity and also to compare with the description of the Down’s foot in current 
literature. Foot type can be determined by the digital formula which is the relative length of the toes 
to one another. Different foot types include square forefoot (all toes of relatively equal length), 
Egyptian foot (big toe longest tapering to little toe), Greek foot (second toe longer than big toe) 
short/broad foot (very broad in relation to length), long slender foot, triangular foot, hypermobile 
foot and low and high arched foot. Shoe type was assessed as an inappropriate shoe can cause 
trauma and deformity to the foot. 
 
Foot and lower limb posture were examined, as postural disorders such as pes plano valgus and 
sub-talar joint pronation can cause discomfort, pain and disability. Orthotic usage was assessed to 
discover how many children were being treated appropriately for postural foot disorders. The 
addition of an orthosis can improve the posture of the foot and improve and correct gait.  
 
Digits, skin conditions and nails were examined as part of the routine podiatric screen although 
nails were specifically examined for nail pitting and striations with regard to a possible link to 
psoriatic arthritis as considered by Cruickshank et al (2008).   
 
Metatarsal formula shows the relative length of metatarsals to one another and the positioning of 
the first metatarsal head. Metatarsal heads are numbered one to five with the relative length from 
longest to shortest displayed within the formula. 21345 known as the index minus formula (second 
metatarsal head sits highest down to fifth sitting lowest) is the most prevalent formula with the 
index plus formula 12345 also considered within normal parameters (Gottschalk et al, 1980; 
Dominguez et al, 2006; Morandi et al, 2009). A metatarsal formula of 23415 could cause a 
pronated foot caused by the first metatarsal head being too short.  
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7.4 Results 
 
30 (45%) feet examined displayed the 2 size differential between foot size and shoe size as 
described above. (Table 7.1). 
 
7.4.1 Footwear 
 
42 (64%) children had footwear with adequate foot support and 23 (35%) had footwear with 
inadequate support with no data on one child. 48 (73%) wore shoes with appropriate heel height 
and 17 (26%) had shoes with too low a heel height. Appropriate heel height was considered to be 
between ½cm and 1½cm as a slight heel height gives a mechanical advantage during locomotion. 
Types of footwear are shown in Table 7.2. 42 (64%) children had had their feet measured. The 
shoes which had inadequate counter and low heel height tended to be plimsolls or converse trainers 
and the material for these shoes were generally canvas or plastic.  
 
7.4.2 Orthotic usage 
 
26 (39%) children had attended orthotics and had foot orthoses fitted for their shoes. 
 
7.4.3 Foot type  
 
25 (36%) of the study population displayed a square forefoot, 27 (41%) a short broad foot and 46 
(70%) a triangular foot which can all have implications for shoe fitting which could lead to 
deformity (Table 7.3). 39 (59%) of the study population displayed hypermobility in the feet. 
 
7.4.4 Foot posture 
 
32 of the children displayed a pes plano valgus which is just under half of the study population. 55 
(83%) showed sub-talar joint pronation in relaxed stance and 49 (74%) showed this during gait. 
(Table 7.5). 
 
7.4.5 Metatarsal formula 
 
32 (48%) children displayed a metatarsal formula of 21345 with another 9 (14%) displaying the 
index plus formula of 12345. 11 children (17%) displayed a formula of 23415 which could lead to 
pronation. 12 children displayed the formula 23145 with the remaining 2 children non-compliant to 
examination (Table 7.4) .  
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Table 7.1: Table showing difference between foot size and shoe size 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foot size to shoe size 
difference 
Number of feet 
/132 (%) 
No data 14 (21%) 
0 10 (15%) 
+ 1 17 (26%) 
+ 1½ 18 (27%) 
+ 2 30 (45%) 
+ 2½ 14 (21%) 
+ 3 22 (33%) 
+ 3½ 3 (4.5%) 
+ 4 2 (3%) 
+ 4½ 1 (1.5%) 
+ 5 1 (1.5%) 
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Figure 7.1: Figure showing foot size to shoe size normal standard  
(Walther et al, 2008)     
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Table 7.2: Table showing types of footwear worn 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shoe type Number of 
children 
(%) 
Lacing 11 (17%) 
Strap 5 (8%) 
Velcro 47 (71%) 
Slip-on 1 (1.5%) 
Pointed 7 (11%) 
Square 7 (11%) 
Round 51 (77%) 
Adequate Counter 42 (64%) 
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           Table 7.3: Table showing foot types in study cohort  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foot type Number of 
children (%) 
Square Forefoot 25 (36%) 
Short Broad 27 (41%) 
Long Slender 20 (30%) 
Triangular 46 (70%) 
Hypermobile 39 (59%) 
High Arched 15 (23%) 
Low Arched 40 (61%) 
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Table 7.4 Table showing metatarsal formula in study cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Metatarsal 
formula 
Number of 
children (%) 
21345 32 (48%) 
12345 9 (14%) 
23415 11 (17%) 
23145 12 (18%) 
No data 2 (3%) 
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Table 7.5 Table showing differing foot postures in study cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foot Posture type Number of 
children (%) 
Posture during 
Gait / Dynamic 
Number of 
children (%) 
Sub-talar joint 
pronation 
55 (83%) 49 (74%) 
Pes Plano Valgus  - 32 (48%) 
Neutral 7 (11%) 13 (20%) 
Supination  1 (1.5%) 1 (1.5%) 
No data 3 (4.5%) 3 (4.5%) 
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Picture 7.1 Picture showing sub-talar pronation with hypermobility 
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7.4.6 Leg length discrepancy 
 
48 (73%) children displayed no leg length differential. 11 (17%) children displayed a leg length 
differential of half centimetre and 7 (11%) children displayed a differential of 1cm .  
 
7.4.7 Nail features and pathologies 
 
Longitudinal and transverse striations were the most common nail changes found with 39 children 
showing longitudinal nail striations (Table 7.6). 
 
7.4.8 Skin pathologies 
 
18 children displayed syndactyly with the majority between 2nd and 3rd toes. 14 children displayed 
anhydrosis and 4 displayed tinea pedis.  
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Table 7.6: Table showing nail changes discovered in the study cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nail changes % of children 
Longitudinal striations 39 (59%) 
Transverse Ridging 9 (14%) 
Involution 5 (8%) 
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Figure 7.2: Figure showing effect too tight shoes can have on toes 
(an initiative of the ‘Kids: Healthy feet – healthy life’ research team: Appendix 9) 
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7.5 Discussion 
 
Foot size to shoe size ration was examined as shoes that are too short can cause deformity to the 
feet and children are especially at risk as their feet are growing, are softer than adult feet and can be 
affected more easily by footwear that is too tight or short as expressed in Figure 7.2. Children with 
DS are especially vulnerable as they are more likely to display a pes plano valgus and a sub-talar 
joint pronation which would require a broader shoe to accommodate the altered physiology. 
However 45 of the feet displayed a difference that was shorter than the recommended standard with 
10 showing a 0 size difference and 17 showing a +1 size difference which means these children 
were in shoes too small for their feet. One child had one foot showing a +2½ size difference and 
the other a +3 size difference but in this case the larger shoe size was required due to the broadness 
of the feet.  32 of the feet examined displayed a two size difference between shoe size and foot size 
taking account of growth, elongation during gait, particularly with hypermobile feet, and 
accommodation for style. 
 
Footwear was assessed for style, retaining medium (how the footwear is held on the foot), toe box 
shape, counter (support in the heel area, particularly medially), material, heel height and base of 
heel. Deformity can arise from poor design in any of these features. In general the footwear was 
very good with round or square toe boxes, adequate counters, velcro retaining mediums, leather 
uppers and an appropriate heel height and base of heel. The style of shoe was typically ‘school 
shoe’ or trainer. A small proportion of footwear was plastic and ‘cheap’ which may reflect the 
current economic climate rather than ignorance or negligence. Most of the parents appeared to be 
making an effort to have good quality footwear and a good fit but educating parents regarding the 
importance of good fitting, suitable footwear is recommended. 
 
Orthotic usage was examined as it is well known that pes plano valgus is an overt feature in DS but 
only a very small proportion of children with this deformity had management with foot orthosis 
and less than 5% had access to a podiatrist or had specialist podiatric assessment. Prescribed foot 
orthotic usage was present in 39% and it appeared to be a lottery as to whether children had been 
referred to orthotics or podiatry or not. Many children with gross deformity had no orthotics 
whereas children with marginal or no deformity were being managed by orthotics. This is an area 
that needs to be addressed urgently with appropriate protocols and specialist assessment. 
 
As discussed in Chapter 5 the feet of this group of children displayed generalised hypermobility, 
especially in the ankles, subtalar and talonavicular joints which did not correlate with the joints 
examined in the Beighton hypermobility scoring system. 
 
A considerable number of foot configurations were identified in this population. The DS foot has 
been described as short and broad with a larger space between the 1st and 2nd metatarsophalangeal 
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joint (Kava et al, 2003; Roizen, 2003; Weijerman and de Winter, 2010; 
http://www.nichd.nih.gov/health/topics/down/conditioninfo/Pages/symptoms.aspx; 
http://www.downsyn.com/joomla/index.php/questions-articles/what-are-the-physical-
characteristics) (Picture 7.1). This was a pattern identified in this population but the space was only 
obvious in a small number of cases. This study showed that the majority of the feet were short and 
broad with an adducted first ray, hypermobile and a low arch suggesting pes plano valgus but 30% 
displayed long, slender feet demonstrating considerable variation in foot type and structure, which 
is not clear in the existing literature.  
 
Foot and lower limb posture were examined to determine the number of children with postural 
defects. The majority demonstrated excessive sub-talar joint pronation and 48% displayed pes 
plano valgus. With pes plano valgus the foot is always flat but with sub-talar joint pronation the 
foot collapses in which could be developmental or pathological and may also be secondary to 
hypermobility, hypotonia and lower limb posture. This is particularly relevant with regard to 
orthotic usage as orthoses can correct sub-talar joint pronation and highlights the need for podiatric 
review of these children. 
 
Eighteen (27%) children displayed syndactyly with the majority occurring between the 2nd and 3rd 
toe. All showed partial syndactyly with the fusion extending only to the proximal inter phalangeal 
joint. This is a large percentage compared to a prevalence found in a study of congenital limb 
defects in Finland of 0.03% (Aro et al, 1982) and an estimated prevalence of 0.04% in the general 
population (Malik, 2012) The location of the syndactyly is the most common pattern and is 
classified as syndactyly type 1. Type 1 syndactyly is one of the most common types demonstrating 
fusion of third and fourth fingers and/or second and third toes (Malik, 2012). Syndactyly may, 
therefore, be more prevalent in DS. Concolino et al (2006) found syndactyly in 10% of their DS 
population compared to 2% in the control population.  
 
Leg length discrepancy was examined in order to determine the possible association with mobility 
problems. All the children displayed a leg length discrepancy of 1cm or under which is considered 
to be within the normal parameters. The literature is conflicting as to when a leg length discrepancy 
becomes a problem but the general consensus is that corrective treatment would not be considered 
in a difference under 2cm (Gibson et al, 1983; McCaw and Bates, 1991; Gurney, 2002; Perttunen et 
al, 2004; Defrin et al, 2005; www.childrensorthopaedics.com/lld/html). 
 
A large number (39) of the children displayed longitudinal ridging on their toe nails with a smaller 
number (nine) displaying transverse ridging . Nail morphology was documented because of interest 
in determining whether psoriasis or nail features were over represented in the population, and any 
relation to psoriatic arthritis following the RHSC Yorkhill pilot study (Cruickshank et al, 2008) 
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which found two of the 12 children who attended had psoriatic arthritis and eight displayed features 
of psoriatic arthritis. Parents of seven of the children in this cohort had described a family history 
of psoriasis in a first degree relative. However this ridging was not clinically typical of psoriasis, 
and it was considered that this may be a peculiarity to toenails in DS rather than a link to psoriatic 
nail changes. A small number (four) displayed nail pitting but this may be due to trauma of the nail 
instead of due to underlying psoriasis.  
 
Many of the foot and lower limb features concur with the literature descriptions in DS but do not 
appear as obvious as would be expected. Foot posture and gait are an issue mainly due to sub-talar 
pronation and hypermobility. Each case should be managed on its own merit and children should 
be screened by a paediatric podiatric specialist experienced in children with DS particularly with 
regard to orthotic management.  
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Picture 7.2: Down’s foot showing wide gap between first and second metacarpal joints 
http://newborns.stanford.edu/PhotoGallery/Downs4.html 
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CHAPTER 8 
 
DISCUSSION 
 
The research objective for this study was to determine the frequency of musculoskeletal 
disorders in children with Down’s syndrome and the levels of associated physical 
disability with particular attention to hypermobility, foot disorders, arthritis and obesity. 
This is the first population survey to examine MSK disorders in children with DS and the 
main finding of the study was the level of hypermobility within this population of 
children, particularly in the lower limbs, with associated podiatric disorders. 
 
Recognising MSK issues in this population of children is complicated by the fact that they 
do not appear to express pain in the same way as the general population. Studies by Lind 
et al (1970), Martínez-Cué et al (1999), Hennequin et al (2000) examined the reduced 
pain perception within the DS population and many of our parents gave us anecdotal 
evidence that their children did not appear to complain of pain, including one boy with 
extensive joint damage whose functional loss was indicative of adaption to pain, but who 
had never expressed pain. This apparent lack of pain causes difficulty in diagnosis, as 
joint pain is generally one of the key symptoms in arthritis and hypermobility in the 
general population. If pain is not described on presentation arthritis or hypermobility may 
not be considered by the health professional first seen despite other symptoms being 
present such as synovitis, crepitus and over extending joints. This lack of pain expression 
is evident in the original case series by Yancey et al, 1984; Olson et al, 1990 and Juj et al, 
2009 as presentation included morning stiffness, limited motion, gait change, fatigue, 
inability to feed or dress and an increasing desire to be carried. Only two of these 25 
patients are described as presenting with pain which correlates with the findings of the 
RHSC Yorkhill pilot study (Cruickshank et al, 2008). In a study of hypermobility in 
children with DS by Livingstone and Hirst (1986) pain is not mentioned in the 
presentation whereas a study of 125 non DS children with recorded hypermobility by 
Adib et al (2005) mentioned joint pain as one of the most common presenting features. 
Lack of pain could cause major implications regarding joint damage and complications 
from undiagnosed MSK disorders such as hip dysplasia and arthritis and also good joint 
function within hypermobility. 
 
The majority of literature describing MSK features in DS describe general hypermobility 
and hypotonia but these are mainly specified as causing hip dysplasia, atlanto-axial 
instability and sub-talar joint pronation. There are no descriptions of hypermobility 
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examining separate joints so our findings that certain joints, particularly the lower limb 
joints, appear to be more hypermobile than others is an important finding.  
 
The main finding of this study that the children in the study cohort were found to be 
particularly hypermobile in the lower limbs had two implications.  Firstly these are the 
weight bearing joints that are most likely to be associated with altered mobility, and 
secondly that the pattern of joints found to be most hypermobile did not correlate with the 
joints examined using the Beighton (Figure 3.1) or Brighton scales (Figure 3.2). Only 11 
children displayed a Brighton score (Figure 3.2) that would diagnose benign joint 
hypermobility syndrome despite all the children displaying at least one hypermobile joint, 
and some very extreme ranges of hypermobility within the affected joints. The lower 
limbs were found to be most hypermobile with the hips being the most common. 
Anecdotally many of the children immediately sat in the lotus position and a large number 
were able to put their feet behind their heads like the boy in Picture 4.1 displaying these 
extreme ranges of joint mobility. Feet were also particularly hypermobile with a large 
number dispaying sub-talar joint pronation and pes plano valgus. Other literature does not 
appear to have examined individual joints, instead using the Carter/Wilkinson score 
(Livingstone and Hirst, 1986) or the Beighton score (Clinch et al, 2011). Livingstone and 
Hirst (1986) followed the Carter/Wilkinson method as described in Chapter 2, examining 
only particular joints. One of their patients presented with a dislocatable hip but hips are 
not mentioned within their results regarding hypermobility. Their conclusions that general 
joint laxity is not present in DS, following a criteria that upper and lower limb 
involvement must be present, does not correlate with the results from this study showing a 
high number of hypermobile joints in these children. Although this is an older scoring 
system the current scoring systems still only look to diagnose the presence of 
hypermobility. There is no system to grade levels of hypermobility and the development 
of a DS specific scoring system would be extremely useful within this population as there 
was a large variability of hypermobility levels in these children, not only in the number of 
jints affected, but the degree of laxity in the joints.  
 
Only 53% of the children had Beighton scores over four which gives one of the Brighton 
major criteria. Debate over whether a higher threshold for defining hypermobility may be 
more discriminatory in children is ongoing.  Smits-Engelsman, Klerks and Kirby (2011) 
suggested that their threshold of five appeared to be classifying children as hypermobile 
incorrectly and recommended raising the level to seven. A Beighton score of over seven 
would only have given 10 (14%) of these children a Brighton major criteria, which was a 
considerable underestimate and mismatch with the level and number of joints that were 
hypermobile documented in this population. However this is still a higher incidence than 
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Clinch et al’s (2011) incidence of 4.2% of their population displaying Beighton scores 
higher than six suggesting that this population of children appears to be more 
hypermobile than the general population, albeit the mismatch in ages made by this 
comparison. These results also support the development of a DS specific system scoring 
levels of hypermobility.  
 
Interestingly, Adib et al (2005) examined 125 non DS rheumatology patients with 
recorded hypermobility and found that the knees had the highest rate for increased range 
of movement and, although the hips and ankles had high rates also, elbows, metacarpal 
joints and wrists had very similar rates unlike this population where the lower limbs were 
found to be considerably more hypermobile than the upper limbs.  They also found more 
than 30% of their study population to have Beighton scores of 8 or 9 in stark contrast to 1 
child in the DS study cohort which, again, suggests that these scoring systems are not 
suitable for the DS population. 
 
Hand and feet joints appear to be the most common joints to display synovitis and 
deformity in this population (Cruickshank et al, 2008; personal communication O Killeen, 
2013) and a new hypothesis around the relationship between extreme hypermobility, lack 
of pain and the pattern and rapidity of deformity from arthritis in the hands suggested that 
the areas of highest hypermobility would be more susceptible to deformity. However 
hands did not display as high a level of hypermobility as feet. A significant and varied 
number of problems were also identified in the feet of these children, many with the 
potential to lead to progressive problems and become more difficult to remedy so we 
would recommend that they should all be seen by a specialist podiatrist who understands 
this population and can refer appropriately for orthotic usage on a regular basis. 
  
The pattern of hypermobility in lower limb joints is particularly concerning in this 
population of children as it affects weight bearing joints which may lead to increased pain 
and discomfort or mobility problems. This was quite evident in some of the anecdotal 
comments from the parents who said that their children would suddenly sit down after 
walking a distance and refuse to walk any further. Some of the parents thought this was 
due to mood or disobedience but were interested in the findings of the lower limb 
hypermobility, particularly feet and hips, and how this may be contributing to discomfort 
from the hypermobile joints.  
 
Hypermobility may also be linked to other issues that are described in DS such as urinary 
tract disorders and voiding disturbances (Bosch, 2003; Mercer et al, 2004; Weijerman and 
de Winter, 2010). Adib et al (2005) commented that urinary incontinence and infections 
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were more prevalent in girls with generalised joint hypermobility. Although specific 
urinary tract disorders are described in DS such as renal malformation, cysts and posterior 
urethral valves (Bosch 2003; Mercer et al, 2004; Weijerman and de Winter, 2010) it may 
be worth considering a link between delayed toilet training and urinary incontinence with 
hypermobility in this population.  
 
Use of a modified CMAS score within the study suggested that this was not useful as a 
proxy for making any assessment of muscle function in this population. The lack of a 
reproducible method to assess hypotonia in contrast to hypermobility was a limitation.  It 
was clear examining these children that both problems often co-exist and together have an 
additive effect on function, but developing robust data on this was not possible without 
development of a robust tool.  Hip joints are heavily supported by a strong musculature.  
Hypotonia may be very important  in contributing to the extreme hypermobility found at 
the hips in these children with DS.   
 
Livingstone and Hirst (1986) concluded that the orthopaedic problems that occur in 
children with DS was related to hypotonia rather than hypermobility in comparison to this 
study’s findings that suggest that joint problems may be linked to hypermobility and 
therefore development of a DS specific tool for measuring hypotonia would be of value 
with regard to joint problems. 
 
Mobility issues may also arise from weight problems as obesity can affect mobility levels.  
The current worldwide epidemic of obesity led to the inclusion of an anthropometric 
component to the study.  Obesity will put pressure on the lower limbs and compound any 
issues already caused by hypermobility in these joints. The unexpected finding of the 
study was that this population of children, usually considered at risk for obesity, had no 
higher levels of obesity that the reference population from a decade ago.    Whilst only 
10% of this study cohort was shown to be obese it is still an important issue to monitor 
the weight and BMI of DS children to prevent weight increase contributing to mobility 
problems. 
 
This study did not find any additional cases of inflammatory arthritis within the children 
examined as part of the study so the RHSC Yorkhill pilot study prevalence of 2.87% 
remains unchanged. A study in Ireland, currently in progress,of a ten-fold larger 
population of children with DS arising despite a remarkably similar total population size 
(both Scotland and Ireland have about 1 million children) has identified undiagnosed 
cases of arthritis at a high rate (21 cases identified from a population of 164 examined to 
date), and suggests a higher prevalence of arthritis is anticipated to be calculated at 
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completion of the study (personal communication Charlene Foley and O Killeen 
September 2013).  It is unclear why the Irish population should appear to have a much 
higher prevalence rate than previous reported rates (Padmakumar et al, 2002; Cruickshank 
et al, 2008; Juj et al, 2009) and it will be interesting to see their final figures. 
 
One of the barriers to correct diagnosis of MSK disorders may be that attitudes towards 
these children can vary as comments from a parent of a DS child with arthritis suggests. 
She was advised by doctors that she should expect mobility issues as he had Down’s 
syndrome but as one of the focus group rheumatologists said ‘I don’t know why their 
expectation is that their mobility should be so poor’. Attitudes to prenatal testing for DS 
and people with DS was examined by Bryant, Green and Hewison (2006) and they 
commented that ‘there was strong agreement that the biggest obstacle to people with 
Down's syndrome having a good quality of life was a society that struggled to include 
people with disabilities’. 
 
One of the children seen as part of the study had displayed a change of gait for a number 
of months. The care home staff thought he had hurt his hip originally but felt that the limp 
was put on as time went on. Children would be unable to continue displaying a limp on 
the same leg if there was nothing wrong, especially children with a learning difficulty so, 
if this child was limping continually, it was suggestive there was definitely a problem. 
This child was seen as having mood issues which probably led to this attitude and, 
although no MSK disorder was diagnosed, he was found to have an undescended testicle, 
which was a very important diagnosis in a teenage boy. This is an example of an altered 
perception or expectations of the physical abilities in this population which may be a 
major contributor to late diagnoses. In a review of literature in palliative care in learning 
disabilities, Tuffrey-Wijne (2003) discussed studies that concluded that in some cases 
diagnosis was delayed because symptom complaints were attributed to learning disability 
which supports this theory and suggests that rheumatology is not the only area where this 
is a problem. 
A number of the children seen by the consultant rheumatologists and identified from the 
RHSC Yorkhill pilot study were given various misdiagnoses which included maternal 
anxiety and developmental issues. This is also present in the previous case studies 
described by Olson et al (1990). ‘Very frequently, pain behavior and changes in activities 
of daily living were attributed to behavioural problems associated with the Down 
syndrome’ (Olson et al, 1990). It appears that the attitude towards these children, 
particularly with regard to MSK disorders, needs to be addressed to allow correct and 
timely diagnosis and early intervention before joint damage can occur. ‘While the 
impairment associated with the condition is real, affected individuals have frequently 
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exceeded expectations and limitations set for them by health professionals’ (Bryant et al, 
2006).  
The recurring theme and most important outcome of this study is the recognition of the 
need for education. In the first instance parents require to be educated on the possibility of 
MSK problems in their children and the requirement to remain vigilant to change of 
function and mood as these should not be dismissed as developmental or behavioural 
problems related to DS. The majority of the parents involved in the study were aware that 
neck and hip problems were possible in their children as checking for atlanto-axial 
instability and hip instability are part of the annual review exam by the community 
paediatricians. Many parents were also aware that their children were particularly 
hypermobile but were not necessarily aware that hypermobility could cause pain and 
discomfort leading to reduced levels of mobility. Those that said their children sat down 
suddenly after walking a distance appeared interested in possible alternative explanations 
such as pain and hypermobility. 
 
An education leaflet giving parents information on various possible MSK disorders such 
as hypermobility, arthritis and joint instability, including signs and symptoms would be an 
extremely useful tool as it would give parents the confidence to query symptoms with 
their health professional and, hopefully encourage the health professional to complete an 
MSK assessment or refer, if unsure. This leaflet should also include information about 
changes in mood or gait, loss of function and adaptations of movement as these children 
may not complain of pain but adapt round any discomfort they may be experiencing. 
Including foot problems and why correct shoe fitting is extremely important in this 
population of children is also vital for parents as keeping their child’s feet healthy will 
help reduce mobility problems. Encouraging the parents to seek podiatric advice would 
also be recommended.  
 
Education on healthy diet and weight management would also be very important for the 
parents as trying to maintain their child at a healthy weight would prevent mobility issues 
occurring or worsening if already present. Information about regular exercise and 
activities should be included. It is recognised that this may not be possible for all children 
with DS as some children may have a deeper learning disability or other problems such as 
autism and it may be more difficult to maintain these children at a healthy weight.  
 
Education will also help address the incorrect impression that these children should have 
mobility issues because of their DS and that regular exercise will help weight 
management and allow them to socialise. Many children with DS participate in exercise 
such a football, athletics, swimming and dance classes and should be encouraged to 
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become involved with sports and exercise alongside children in the general population. 
This will help improve the attitudes towards mobility levels and issues in these children. 
Indeed good work in raising expectation for the sporting achievements is seen in the 
petitions and campaigns for people with DS to compete in the Paralympics as the 
categories between physical disabilities and learning disabilities excludes them at present.  
 
Education of the various health professionals who see these children regularly is also vital 
to prevent mobility problems and allow timely diagnosis of any disorders present. This 
would include general practitioners, community paediatricians, physiotherapists, 
occupational therapists and school nurses. This should include information on general 
mobility in this population of children to remove the attitude that these children will have 
mobility issues due to their DS and raise awareness that children in this population are 
more likely to present with a gradual decrease in function or a change in behavior rather 
than an acute painful presentation. The annual health checks would be the ideal 
opportunity to identify any of these issues and refer where appropriate. Discussing 
palliative care in learning disabilities Tuffrey-Wijne (2003) commented that a particularly 
under researched area was how people with learnin disabilities express and experience 
their symptoms which needs to be addressed.  
 
General practitioners (GPs) and community paediatricians should be educated in how to 
undertake an MSK examination in children to identify multiple MSK disorders which 
would benefit the general population of children as well as the DS population. Education 
for GPs and community paediatricians should also include information about pain 
perception in this population as this is an extremely important factor in recognising 
arthritis and other MSK disorders. Pain in the joint is usually one of the first symptoms a 
child will complain about which may lead the parent to notice other symptoms, if present. 
Reduced pain perception in the DS population make identifying MSK problems harder 
and these health professionals will require extremely well developed examination 
techniques. 
 
One of the focus group rheumatologists thought that the lack of complaints of pain may 
be why arthritis was not considered as a diagnosis in some of the children who presented 
late with joint destruction. It is, therefore, very important that the health professionals 
who see these children regularly are aware that a child presenting with reduced mobility, 
change in gait or mood, swollen or stiff joints or crepitus in a joint are most likely to be 
presenting with inflammatory arthritis or other significant MSK disorder even if the child 
is not complaining of any pain.  
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The rheumatology department at RHSC Yorkhill run an annual educational meeting 
which provides education on MSK examination techniques, orthopaedic problems, 
diagnosing MSK and connective tissue disorders and reading Xrays. GPs and community 
paediatricians should be encouraged to attend such educational meetings to improve their 
knowledge of rheumatological and orthopaedic disorders. Education can also be given in 
the form of educational leaflets, DVDs and on site training.  
 
While we would recommend educating in MSK disorders, our focus group suggested that 
community paediatricians may not welcome an additional examination within the annual 
review process, in addition the identification of MSK problems appears from the study to 
be particularly challenging, and require high quality MSK examination skills that are well 
developed and well maintained.  Whilst education of community paediatricians to use 
existing MSK examination tools such as pGALS would be a useful way forward, we also 
consider that this might still lead to difficulties in identifying pathology. This study 
recommends the creation of a DS specialist nurse who can liaise with the families 
regarding all aspects of their care and could also be trained in MSK examination. They 
could facilitate coordination of appointments between specialties to the same day, if 
possible, to prevent too many separate appointments taking up the family’s time, shared 
general anaesthetics for more than one procedure, and many other organisational skills 
that would be of benefit. One parent taking part in the study declined the referral to 
paediatric rheumatology because she already had enough appointments to attend. A nurse 
specialist would be able to help educate the parents and support them with any concerns. 
In her interview with Arthitis Today magazine one parent commented ‘if we hadn’t been 
his parents, pushing all the time, he wouldn’t be diagnosed yet’ (Tadman, 2012). Some 
parents may not know that there is something wrong and to push for a correct diagnosis 
but a nurse specialist could liaise with the health professionals to ensure the child’s 
healthcare journey is thorough and appropriate. The nurse could also facilitate correct 
podiatric referral to ensure ongoing footcare and appropriate orthotic usage. This nurse 
working with one group of patients over a wider geographic area would become more 
skilled at making these assessments, would not be working with large numbers of 
neuromuscular disability which requires different skills, and would develop relationships 
with relevant specialist services, such as paediatric rheumatology, podiatry, cardiology 
and haematology, becoming very skilled in identifying the specific needs for these 
children and families. Sloper et al (2006) examined the use of key workers in children 
with disabled children which included 15 children with DS. They commented that 
research into the use of key workers suggested that these families are better informed, 
have higher morale and have a better involvement and relationship with the services they 
use.  
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Development of a DS specific MSK examination tool, equivalent to pGALS, taking into 
account the differences this study has identified in the MSK pathologies and their 
presentations in this population, is a key development to facilitate early and confident 
MSK assessment where MSK presentations are difficult and different in this population. 
 
8.1 Study limitations   
 
The main study limitation was performing a population study in children with learning 
difficulties as we were unaware how co-operative the children would be. Generally the 
majority of the children were compliant with the study visit, however, there were some 
children who were only compliant with certain aspects of the visit and a complete 
assessment was not obtained. 
 
Recruitment was an issue for the study with 36% not responding to the study invitation. It 
was considered, though, that this group of children already have a large number of clinic 
and hospital appointments and the parents may have decided they already had enough 
appointments without involving themselves in another. Deprivation category was not 
documented for the study population but would have been a useful tool to assess any 
difference between the parents who agreed to participate and those who did not respond. 
 
As discussed in Chapter 3 a number of the various tests used in this study were found to 
be unsuitable for this population of children. However, this gave us interesting results to 
compare to the tests such as the comparison of hypermobile joints within the Beighton 
scoring system. 
 
It was discovered that the CHAQ questionnaire was not useful within this population as it 
is aimed at scoring for function limitations in arthritis and it was unclear if parents were 
scoring around their children’s DS rather than any MSK issues. This meant the scoring 
was not valid for assessing for MSK problems in these children. 
 
The CHQ questionnaire was also considered not to be useful for the same reasons as it is 
a well-being questionnaire for children with an underlying disease and, again, was 
unclear if completed around the child’s DS rather than any MSK problems.  
 
The Beighton score proved to be unreliable in this population as the majority of joints 
found to be hypermobile did not correlate with the ones examined within the Beighton 
score. Similarly the Brighton score, used in conjunction with the Beighton score was not 
useful in diagnosing hypermobility syndrome as discussed in Chapter 5.  
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Bioelectrical impedance measurements were taken but there was no data to compare them 
with to assess the significance of impedance values in this population and 25% of the 
children did not stand still long enough on the Tanita scales to allow for an impedance 
measurement.  
 
The Schober’s test had limitations in this population due to compliance and 
understanding of instructions. 16 children were non-compliant with the test and it was 
difficult to ascertain if the children who showed a result under 21 had understood the 
instructions and the lower result was due to a limitation or non compliance.  
 
The patient questionnaires were devised to receive answers to issues we wished to 
address within the study. However, if the study were to be repeated, we would include 
more open ended questions and supplementary questions as a small number of parents 
answered yes to a question regarding any MSK concerns without giving any further 
details.  
 
Pubertal status was not documented within the study but would be considered in a further 
study as it is an important consideration in growth and development.   
 
The focus groups were limited for a number of reasons previously discussed in Chapter 4. 
 
If the study was to be repeated various changes would be made to improve the data 
outcome such as improved questionnaires, assessing an alternative method of recruitment 
to improve participant numbers, improving the facilitation of any focus groups and using 
the study to try and identify suitable tools for this population of children. 
 
8.2 Recommendations and future work 
 
We would recommend the development of education tools on MSK disorders and 
examination such as information leaflets and study days for health professionals involved 
with the care of these children to allow better understanding and awareness of MSK 
issues and information leaflets for parents to allow them to understand what symptoms to 
be aware of. This will facilitate early diagnosis and greatly improve the prognosis for 
these children on presentation at rheumatology. It may be possible to develop information 
leaflets in collaboration with Arthritis UK. 
 
We would also recommend the inclusion of an MSK examination such as pREMS to be 
incorporated into the annual review of children with DS. 
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Appropriate podiatric examination would be recommended for this population by a senior 
paediatric podiatrist, preferably one who is experienced in this population of children and 
can assess for appropriate orthotic referral. 
 
Following on from this study, it would be advantageous to compare our results with the 
results of the population study in Ireland (personal communication O Killeen and C 
Foley), although they appear to have a much higher DS population which may be a result 
of Irish anti-abortion laws, and then consider repeating this study with a larger population 
group to try and establish a more definitive conclusion on MSK disorders in this 
population. 
 
8.3 Summary and Clinical Implications 
 
In conclusion this study did not discover any new cases of arthritis among the cohort and 
the RHSC Yorkhill pilot study prevalence of 2.87% remains unchanged. This percentage 
suggests that arthritis may be more prevalent in the DS population but further studies with 
a larger cohort or covering a wider area are underway and may establish a much higher 
prevalence (personal communication O Killeen and C Foley, 2013). 
 
This population of children is shown to be extremely hypermobile but mainly in lower 
limbs leading to mobility problems, which does not correlate with the Beighton scoring 
system. A full examination of all joints in these children is recommended to establish 
level of hypermobility, and a specific DS hypermobility tool would be very valuable as 
the Beighton and Brighton scoring systems do not appear to be compatible with the joints 
found to be hypermobile in this study cohort. 
 
Regular contact with a podiatrist experienced in children and especially DS children is 
highly recommended to improve quality of foot care and appropriate orthotic usage. 
 
One positive outcome from the study is that referral rates to rheumatology from 
community paediatrics has increased and, therefore raised awareness regarding MSK 
problems in children with DS as we believe that the most important message from the 
study is that education of parents and health professionals is vital to improve knowledge 
and awareness of the signs and symptoms of MSK disorders and MSK complications 
within the DS population to ensure early diagnosis and appropriate management.  
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This group of children are found to be at risk of mobility problems due to MSK disorders 
but, if awareness is improved following this study and it is possible to create DS specific 
tools to examine and assess for MSK problems, the risk can be reduced and mobility 
problems can be minimised to allow good quality of life and improvement in outcome and 
prognosis.  
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APPENDIX 2: PARENT AND PATIENT INFORMATION SHEETS 
AND INVITATION 
 
 
NHS Greater Glasgow & 
Clyde 
Royal Hospital for Sick Children 
Dalnair Street 
Glasgow G3 8SJ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What is the study about? 
Children and young people with Down’s Syndrome often have very bendy joints that get 
sore, and sometimes the joints are swollen because of arthritis.  We don’t know how often 
this happens, but we know some children with Down’s syndrome have these problems for 
a long time without anyone knowing.  If we knew we could help prevent damage to the 
joints.  We want to check the joints of all children with Down’s syndrome in Glasgow to 
find out how common these problems really are. 
  
What will happen? 
We would like to come to see your child once. You can choose for the visit to be in your 
home, at school, at your next clinic visit to your community paediatrician or at the Clinical 
Research Facility at Yorkhill Hospital. We will look, feel and move your child’s muscles, 
bones and joints and feet, and measure your child’s height and weight. It will be friendly 
and relaxed for your child, and easy for them to do.  All we ask is that you bring shorts and 
a T shirt for your child to wear so they feel comfortable. 
 
Who is organising the research? 
The paediatric rheumatology team at Yorkhill is organising the study. You can contact Sr. 
Maureen Todd, the research nurse on the telephone 0141-232 1836; mobile 07760 
240415 or e-mail maureen.todd2@nhs.net .  Dr Gardner-Medwin is the consultant in 
charge of the study. You can contact her on telephone number 0141 232 1836/1837 or 
email Janet.Gardner-Medwin@glasgow.ac.uk . Your child’s own community doctor also 
knows about this study, and you can ask them questions if you prefer. 
 
We will ring you in the next day or so to answer any questions, and find out if you would 
be happy to help us. 
Thank you very much for taking the time to read this sheet. 
Can you help us? 
 
We are inviting you and 
your child to take part in 
a research study 
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Parent/Guardian Information Sheet 
 
 
Study Title:  Study of incidence of musculoskeletal abnormalities in children with 
Down’s syndrome in the Glasgow population 
Study Staff: Sr. Maureen Todd, Prof. Jim Woodburn, Dr Malcolm Donaldson, Jez Jones, 
Dr Kath Leyland, Mr Gordon Watt, Prof. John McColl and Dr Janet Gardner-Medwin 
 
 
Your child is being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read this information carefully.  Please ask us if there anything is not 
clear. Take time to decide whether you wish your child to take part. 
 
What is the purpose of the study? 
Children with Down’s syndrome can get problems with their bones, joints and muscles. 
Many children with Down’s syndrome are very flexible, and some get arthritis. We want to 
find out how common these problems are, and whether they cause serious physical 
problems. We are concerned they are often overlooked leaving children in pain or with 
difficulty getting about which adds to their difficulties.  Finding these problems early 
would improve the well-being of these children.  
 
Why has my child been chosen? 
We are inviting all children with Down’s syndrome, who are between 2 and 16 years old, 
and who live in Glasgow to take part. 
 
Do we have to take part? 
No. It is up to you to decide whether or not your child takes part. We have designed the 
study to be easy for children with learning difficulties and other physical problems to take 
part, and we are happy to talk to you about how we can make the visit as easy for your 
child as possible.  If you think that your child cannot take part at the moment we would be 
happy to invite you at a better time for your family. If you do decide to take part, you will 
be given this information sheet to keep and asked to sign a consent form. You are free to 
withdraw at any time without giving a reason. A decision not to take part will not affect the 
standard of care your child receives. 
 
What will happen to my child if he/she takes part? 
We would like to come to see your child once. This can either be at your home, at school, 
at your next routine visit to your community paediatrician or you can come to the Clinical 
Research Facility at Yorkhill Hospital. You can let us know what would be most suitable 
for you. We are very happy to answer any further questions before you decide to join the 
study. Once you have decided to take part we will ask you to sign a consent form.  With 
your help the research nurse will learn about your child’s medical story, your child’s daily 
activities, physical abilities and whether you think they get any pain or discomfort. We will 
ask about anyone in the family with arthritis or similar conditions.  Then the research nurse 
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will do a simple examination of your child’s muscles, bones and joints. This involves 
looking, feeling and moving the bones and joints. A foot expert will look at your child’s 
feet. We will measure your child’s height and weight 
 
What do we have to do? 
Getting in touch: We will already have contacted you to ask if you would like to take part.  
We are happy to answer any further questions you have, find out what arrangements will 
suit you and 
your child best, and arrange a visit.  You can contact us if you prefer, our details are at the 
end of this sheet. 
Explaining to your child: We enclose different information, and ask you to choose which 
one best suits your child. You are the best person to choose whether this information suits 
your child’s level of understanding. It may be you feel it best to explain the study in your 
own words. 
The visit:  On the day of the visit please bring shorts and T-shirt for your child to wear. At 
the visit you will meet Maureen Todd, the research nurse, and Gordon Watt, the foot 
expert.  We will make sure you and your child are happy to take part, and you will be 
asked to sign a consent form. Children who would like and are able can sign an assent 
form. 
All the measurements are very simple. We want your child to be comfortable, relaxed and 
to enjoy the visit. We know children with Down’s syndrome sometimes need a little extra 
encouragement and time, and might even decide not to cooperate so please don’t worry.  
We have allowed an hour for the study which is plenty of time. If things go very quickly it 
won’t take that long. We will be sensitive to how your child feels on the day, and stop if 
they don’t want to go on. 
Maureen will measure your child’s height and weight. Then she will look at your child’s 
bones, muscles and joints in detail. Gordon will examine your child’s feet and watch them 
walk. We will ask you some general questions about your child and your family’s health.  
One of the study staff will be free to play or care for your child while you answer 
questions, or ask us questions. Your child can rest, have a snack or play whilst we answer 
your questions and tell you the results of the visit. You will then have finished your part in 
the trial, thank you. 
 
Is there any disadvantage in taking part? 
We will tell you everything we found during the visit. With your permission, we will tell 
your family doctor and community / school doctor. If we find a problem you didn’t already 
know about, or if you wish for a further medical opinion we can arrange an outpatient 
clinic appointment for your child at Yorkhill. It is entirely up to you to decide if you would 
like an appointment. You can discuss this with your child’s own doctors before making up 
your mind, and you can ask for an appointment later. We would be happy to see your child 
anytime up to their 18th birthday.  You are of course able to arrange with your own doctor 
for a referral elsewhere if you prefer. 
 
What will happen to the results of the research study? 
Any information collected during this study will be kept strictly confidential.  Each 
participant will be given a code number so that they cannot be identified. All data will be 
stored on a secure database that can only be accessed by authorised individuals. The results 
will be published in a medical journal. It will not be able possible to identify your child in 
this publication. It will say general things like “150 children aged 2 to 17 were examined”. 
We would like to tell you the overall results of the whole study after it is finished. 
However this will take some time, so it will probably be 2012 by the time the study is 
finished and we write to you. 
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Who is organising the research? 
The paediatric rheumatology team at Yorkhill is organising the study. If you have any 
questions, problems or difficulties with the study, please contact Sr. Maureen Todd, the 
research nurse, on the telephone 0141-232 1836; mobile 07760 240415 or e-mail 
maureen.todd2@nhs.net. Dr. Janet Gardner-Medwin, Consultant and Senior Lecturer in 
paediatric Rheumatology is in charge of the study. You can contact her on telephone 
number 0141 232 1836/1837.This study has been approved by a medical ethics research 
committee. They are happy that this study is of a good standard. This information sheet is 
yours to keep. We are very grateful to children and their families for helping with research. 
Thank you very much for taking the time to read this information sheet. 
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NHS Greater Glasgow & Clyde 
Royal Hospital for Sick Children 
Dalnair Street 
Glasgow G3 8SJ 
 
 
  
 
Patient Information Sheet No. 1 
 
 
Study Title:  Study of incidence of musculoskeletal abnormalities in children with 
Down’s syndrome in the Glasgow population 
Study Staff: Sr. Maureen Todd, Prof. Jim Woodburn, Dr Malcolm Donaldson, Jez Jones, 
Dr Kath Leyland, Mr Gordon Watt, Prof. John McColl and Dr Janet Gardner-Medwin 
 
 
We are inviting you to take part in a research study. This is to tell you about the research. Please 
take time and discuss it with your parents before you decide to take part. Please ask if you have 
any questions.  
 
What is the study about? 
Children and young people with Down’s Syndrome can have very bendy joints that get sore, and 
sometimes they can get sore swollen joints.  We don’t know how often this happens, but we think 
some children may have these problems without anyone knowing.  If we knew we could help.  This 
study is to find out how often these problems happen. 
 
Why have I been chosen? 
We are inviting all children and young people with Down’s syndrome who live in Glasgow to help 
us.  
 
Do I have to take part? 
No. It is up to you to decide whether or not you take part. If you do decide to take part, you can 
keep this information and if you wish you can sign to say you are happy to take part.  
You can stop whenever you want.  
 
What will happen to me if I take part? 
We will see you just once. This can be at your home, at school, at your next routine visit to the 
school doctor or at the Clinical Research Facility at Yorkhill Hospital. We are very happy to answer 
any questions before you start. We will ask you and your parents about your health. Then the nurse 
will look, feel and move your muscles, bones and joints. A foot expert will look at your feet. We will 
measure your height and weight. You can help us with the questions we ask you and your parents 
about your health. 
 
 
What do I have to do? 
Talk to your Mum or Dad and if you want to do the study they will let us know.  On the day it is best 
to wear shorts and T-shirt so we can see your arms and legs. You will meet Maureen Todd, the 
nurse, and Gordon Watt, the foot expert.  After we have done the measurements you will then have 
finished, thank you. 
 
Will you tell me what you found? 
Yes, we will tell you, your parents and your doctor everything we found.  However, no one else will 
know you took part.   
Thank you 
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Dalnair Street 
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Study Title:  Study of incidence of musculoskeletal abnormalities in children with 
Down’s syndrome in the Glasgow population Study Staff: Sr. Maureen Todd, Prof. Jim 
Woodburn, Dr Malcolm Donaldson, Jez Jones, Dr Kath Leyland, Mr Gordon Watt, Prof. 
John McColl and Dr Janet Gardner-Medwin 
 
Patient Information Sheet No. 2 
We are doctors and nurses who care for children who have difficulties in moving.  We 
would like to see children like yourself and check out your movement.  We would like to 
come and visit you and your parents to do this, if you and your Mum and Dad say it is OK. 
You don’t have to help if you don’t want to.  
 
What will happen? 
My name is Maureen, I am a 
nurse and here is a picture 
of me. 
 
 
 
I will measure how 
tall you are 
                     
 
 
            
       and weigh you 
 
 
 
            
 
 
I will have a look at your hands, arms, legs and feet to see how you move. These pictures 
show some of the movements.  I will ask you to copy them.  
 
 
 
 
 
 
 
 
 
 
 
 
        This is Gordon Watt. 
 
 
 
 
 
 
 
 
 
 
 
He will have a look at your feet. 
 
 
 
 
Then you can have a snack or play, while we talk to your parents. 
Then it will be time to go home. Thank you very much for helping us.  
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Study Title:  Study of incidence of musculoskeletal abnormalities in children with 
Down’s syndrome in the Glasgow population Study Staff: Sr. Maureen Todd, Prof. Jim 
Woodburn, Dr Malcolm Donaldson, Jez Jones, Dr Kath Leyland, Mr Gordon Watt, Prof. 
John McColl and Dr Janet Gardner-Medwin 
 
 
Patient Information Sheet No. 3 
 
This is what will happen when we visit. 
 
My name is 
Maureen, I am a 
nurse 
 
 
 
  How tall are you 
 
     
 
 
 
How heavy are 
you? 
 
 
 
 
Can you do this?   Or this?    Or this? 
 
 
 
 
 
 
 
 
 
 
 
    
My name is Gordon Watt.   
 
 
 
 
 
 
       
 
 
 
 
 
 
Can I look at your feet? 
Time for a snack before you go 
home. Thank you
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Community Child Health 
Services 
Southbank Child Centre 
207 Old Rutherglen Road 
Glasgow 
G5 ORE 
 
 
 
 
 
 
 
 
{Date} 
 
 
Dear Parents of {child’s name} 
 
I am writing to ask if you might be able to help us with a research study. This would 
involve a one off short study visit lasting approximately 30 - 45 minutes. 
 
Children and young people with Down’s Syndrome often have very bendy joints that get 
sore, and sometimes the joints are swollen because of arthritis.  We don’t know how often 
they get these problems and would like you to help us learn more by taking part in a 
study. 
 
In the study we will look at your child just once, by looking at your child’s arms and legs.  
There are no tests, just a gentle look at your child.  We will tell you everything we find so 
that it can be used to help your child. This can be done at the same time as your review 
appointment here at the clinic or it can be done at the clinic on another day that suits you 
better, at the Clinical Research Facility at Yorkhill Hospital or in your own home. 
 
I enclose a flyer telling you a bit more. I, or the study staff, would be happy to answer any 
questions you have. 
 
I hope you will feel able to take part so we can learn more about this, and get better at 
helping the children who have these problems 
 
 
 
 
Many thanks 
 
Yours sincerely 
 
 
Dr K Leyland 
Consultant Community Paediatrician 
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APPENDIX 3: pREMS 
 
Supplementary Appendix 1:  pediatric Regional Examination of the Musculoskeletal 
System (pREMS)   
 
General Principles 
Introduction 
¨ Introduction of assessor to child and parent / carer 
¨ Explanation of what to be examined, Gain verbal consent to examine 
¨ Be aware of normal variants in leg alignment, joint range, gait, developmental milestones  
Look for: 
¨ Swellings, Rashes , Muscle wasting , Scars 
¨ Deformity / Dysmorphism / Discomfort (nonverbal) / “Disproportions” 
Feel for: 
¨ Temperature, Swelling, Tenderness 
Move 
¨ Full range of movement – active and passive 
¨ Restriction – mild, moderate or severe 
Function and measure  
¨ Functional assessment of joint / anatomic region to include power of muscles and stability  
¨ Measurement of height / leg length  
Additional Options pending clinical scenario  
 
Examination schedules by anatomical region (note - the components underlined are 
those additional to adult REMS and the components in italics are those deemed to be 
appropriate for the specialist trainee in pediatric rheumatology to be aware of but not 
necessarily competent) 
Examination of the hand and wrist 
¨ Look at the hands (palms and backs) for muscle wasting, joint swelling, skin and 
nail changes 
¨ Feel for radial pulse, tendon thickening and bulk of thenar and hypothenar 
eminences 
¨ Feel for skin temperature 
¨ Squeeze metacarpophalangeal joints (MCPJs) 
¨ Bimanually feel /palpate small joints of the hands including wrists and especially if 
there are swollen or painful joints or restricted movement noted) 
¨ Look and feel along ulnar border 
¨ Assess full finger extension and full finger tuck 
¨ Assess wrist flexion and extension, abduction and adduction  – active and passive 
¨ Assess function: grip and pinch, picking up small object, writing / drawing 
¨ Option – hypermobility syndromes, muscle power, capillaroscopy, peripheral 
nerves  
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Examination of the elbow 
¨ Look for carrying angle, scars, swellings or rashes, deformity  
¨ Feel for skin temperature 
¨ Feel over head of radius, joint line, medial and lateral epicondyles 
¨ Assess full flexion and extension, pronation and supination – actively and passively 
¨ Assess function – e.g. hand to nose or mouth, hands behind head 
¨ Option – hypermobility syndromes, muscle power, entheses, instability tests  
 
Examination of the shoulder 
With the patient standing or sitting: 
¨ Look at the shoulders , clavicles and sternoclavicular joints from the front, side 
and behind and assess shoulder height 
¨ Look at the skin in axillae and palpate for lymphadenopathy 
¨ Assess skin temperature 
¨ Feel bony landmarks and surrounding muscles 
¨ Assess movement and function: hands behind head, hands behind back 
¨ Assess (actively and passively) external rotation, flexion, extension and abduction 
¨ Observe scapular movement 
¨ Options – hypermobility syndromes, muscle power, instability 
 
Examination of the hip 
With the patient supine lying on couch: 
¨ Look for flexion deformity and leg length disparity 
¨ Check for scars, rashes 
¨ Feel the greater trochanter for tenderness 
§ Assess full hip flexion, internal and external rotation, abduction and adduction  
§ Perform Thomas’ test 
§ Hip abduction (lying on side) 
Patient lying prone on couch  
§ SIJ palpation 
§ Hip internal (and external) rotation  
With the patient standing: 
¨ Assess posture and leg alignment  
¨ Look for gluteal muscle bulk 
¨ Perform the Trendelenburg test 
¨ Assess function (gait with turning and running, ancillary movements) 
¨ Options – hypermobility, muscle power, entheses, thigh foot angle (child with 
intoeing) 
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Examination of the knee 
With the patient standing: 
¨ Look for varus/valgus deformity, hyperextension and popliteal swellings 
¨ Look at the skin for pattern of bruising and rashes 
¨ Assess gait (see hip) 
With the patient lying on couch: 
¨ Look from the end of the couch for varus/valgus deformity, muscle wasting, scars 
and swellings 
¨ Look from the side for fixed flexion deformity 
¨ Check for passive hyperextension and leg length discrepancy  
¨ Feel skin temperature 
¨ With the knee slightly flexed feel/palpate the joint line and the borders of the 
patella 
¨ Feel the popliteal fossa 
¨ Perform a patellar tap and cross fluctuation (bulge sign) 
¨ Assess full flexion and extension (actively and passively) 
¨ Option - Assess stability of knee ligaments – medial and lateral collateral – and 
perform anterior draw test 
¨ Option – tests for ant knee pain / patellar maltracking / apprehension / patella 
glide  
¨ Option – hypermobility, muscle power, entheses,  hamstring tightness, iliotibial 
band tightness, thigh-foot angle 
 
Examination of the foot and ankle 
With the patient lying supine on couch: 
¨ Look at dorsal and plantar surfaces of the foot 
¨ Feel the skin temperature 
¨ Feel/palpate for peripheral pulses 
¨ Squeeze the MTPJs 
¨ Feel/palpate the mid-foot, ankle joint line and subtalar joint 
¨ Assess movement (actively and passively) at the subtalar joint (inversion and 
eversion), the big toe (dorsi- and plantar flexion), the ankle joint (dorsi- and 
plantar flexion) and mid-tarsal joints (passive rotation) 
¨ Look at the patient’s footwear 
¨ Option – hypermobility, muscle power, entheses, capillaroscopy, thigh foot angle 
With the patient standing: 
¨ Look at the forefoot, mid-foot (foot arch) and the hindfoot  
¨ Assess gait cycle (heel strike, stance, toe off), running and turning 
¨ Assess muscle bulk (calves) 
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Examination of the spine 
With the patient standing: 
¨ Look at the spine from the side and from behind 
¨ Look at the skin and natal cleft  
¨ Look at limb and trunk proportions  
¨ Look at the face and jaw profile  
¨ Feel the spinal processes and paraspinal muscles and Temporomandibular joints 
(TMJs) 
¨ Assess movement: lumbar flexion and extension and lateral flexion; cervical 
flexion, extension, rotation and lateral flexion, thoracic rotation  
¨ Assess TMJ opening   
¨ Options – Schober’s test, “stork test” 
With the patient sitting on couch (standing in younger child): 
¨ Assess thoracic rotation 
With the patient lying on couch: 
¨ Perform straight leg raising and dorsi-flexion of the big toe 
¨ Assess limb reflexes 
¨ Option – leg length, hypermobility, sacroiliac joint palpation  (Faber’s / Patrick’s 
test) 
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APPENDIX 4: CHAQ FORM 
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APPENDIX 5: CHAQ ADOLESCENT FORM 
 
Name: Surname: Unit No: 
 
CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE 
Adolescent Version 
 
THIS FORM IS FOR ADOLESCENTS OLDER THAN 11 YEARS OF AGE 
 
We are interested in learning how your illness affects your ability to function  
in daily life. Please feel free to add any comments on the back of this page.   
In the following questions, please tick the one response which best describes  
your usual activities OVER THE PAST WEEK. ONLY NOTE THOSE  
DIFFICULTIES OR LIMITATIONS WHICH ARE DUE TO ILLNESS. 
In the end, please go back and check once again that every item has been answered . 
 
  Without With With
 UNABLE ANY SOME MUCH 
 To do Difficulty difficulty difficulty   
DRESSING & PERSONAL CARE 
Are you able to: 
- Dress, including tying shoelaces and doing  c c c c 
   buttons? 
- Shampoo your hair? c c c c  
- Remove socks? c c c c  
- Cut fingernails? c c c c  
 
GETTING UP 
Are you able to: 
- stand up from a low chair or floor? c c c c  
- Get in and out of bed ? c c c c   
 
EATING 
Are you able to:  
- Cut your own meat? c c c c  
- Lift a cup or glass to mouth? c c c c  
- Open a new cereal box? c c c c  
 
WALKING 
Are you able to: 
- Walk outside on flat ground? c c c c  
- Climb up five steps? c c c c  
 
* Please tick any AIDS or DEVICES that you usually use for any of the above activities: 
 
Devices used for dressing  c (eg. button hook, zip pull,  
  long-handled shoe horn) 
Walking stick c  
Walking frame c Built up pencil or special utensils 
 c 
Crutches c Special or built up chair  
 c 
Wheelchair c 
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Other ________________________  c
   
 
 
* Please tick any categories for which you usually need help from another person  
BECAUSE OF PAIN OR ILLNESS: 
Dressing and personal care               c       Eating    c 
Getting up                                          c       Walking    c 
222 
 
 
  
    Without  With    With  
UNABLE ANY  SOME         MUCH  
TO DO             Difficulty  Difficulty Difficulty  
HYGIENE 
Are you able to: 
- Wash and dry your entire body? c c c c  
- Take a bath (get in and get out)? c c c c  
- Get on and off the toilet? c c c c  
- Brush teeth? c c c c  
- Comb/brush hair?      c  c  c  c   
REACH 
Are you able to: 
- Reach and get down a heavy object such as a  
large game or books from just above your head c c c c  
   
 Bend down to pick up clothing or a piece  
 of paper from the floor?               c       c               c         c  
- Pull on a jumper over your head? c c c c  
- Turn neck to look back over shoulder? c c c c  
 
GRIP 
Are you able to:  
- Write with pen or pencil? c c c c  
- Open car doors? c c c c  
- Open jars which have been previously opened?c c c c  
- Turn taps on and off? c c c c  
- Push open a door when you have to  
  turn a door knob? c c c c 
    
 
ACTIVITIES 
Are you able to: 
- Run errands and shop? c c c c  
- Get in and out of a car or school bus? c c c c  
- Ride bike or tricycle? c c c c  
- Do household chores (e.g. wash dishes,  
take out rubbish, hovering, gardening, 
make bed, clean room)?  c c c c  
   
- Run? c c c c  
 
* Please tick any AIDS or DEVICES that you usually use for any of the above activities: 
 
Raised toilet seat c  
Bath rail c 
Bath seat c  
Long-handled appliances for reach c 
Jar opener (for jars previously opened) c  
Long-handled appliances in bathroom c 
 
* Please tick any categories for which you usually need help from another person BECAUSE 
OF PAIN OR ILLNESS: 
 
Hygiene c  
Gripping and opening things c 
Reach c  
Errands and chores c 
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PAIN :  How much pain do you think you have had IN THE PAST WEEK? Place a mark on the line below, 
 to indicate the severity of the pain 
 
 No pain 0                               100 Very  
          severe pain 
GENERAL EVALUATION: Considering all the ways that arthritis affects you, rate how you are doing by 
placing a single mark on the line below. 
 
Very well 0                                100 Very poor 
 
 
Please tell us the date on which you completed this form    
Date:………………………………………………………. 
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APPENDIX 7: GLASGOW ENTHESITIS SCALE 
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APPENDIX 8: PODIATRY EXAMINATION FORM 
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APPENDIX 9: KIDS SHOE FITTING 
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